nct_id,brief_title,page_rank_score_brief_title,page_rank_score_brief_title_summary_combined
NCT01728181,A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic Evaluation,0.0006825983597905101,0.0007879728604259108
NCT01731587,Anti-cancer MUC1-specific Immunotherapy for Unresectable Stage III Non-small Cell Lung Cancer,0.0006070910045617511,0.0006816047000951044
NCT01710319,Mechanisms of Immunosurveillance for Lung Cancer,0.0009021799653660105,0.0005943586724863186
NCT01752101,Identification of a Plasma Proteomic Signature for Lung Cancer,0.0005255409530150316,0.0004790247580351246
NCT01788566,A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Squamous Lung Cancer,0.0005375101352848902,0.0006103310474956372
NCT01748981,"Fitness, Activity and Lung Cancer Study",0.000777608337676725,0.0004469542542218112
NCT01770795,A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung Cancer,0.0007065531076586638,0.0006889269301261579
NCT01727076,"Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer",0.0007457030820519831,0.0008034760642298751
NCT01744925,Icotinib at Different Doses in Second-line Treatment for Non-small Cell Lung Cancer Patients With Wild Type EGFR,0.0008454757109076226,0.0009545071430588242
NCT01767974,Comparison of Sequencing and PNA Clamping of EGFR Gene in Patients With Non-Small Cell Type Lung Cancer,0.0007076218058149496,0.0005856710427368298
NCT01755624,Effect of TTFields (150kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-5 Brain Metastases Following Optimal Standard Local Treatment (COMET),0.0007535159995907102,0.0007216687296576181
NCT01707888,VATS Major Lung Resection for Chinese Early-stage Non-small Cell Lung Cancer,0.0006226829663178321,0.0008058134310804904
NCT01741155,Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer (NSCLC),0.0006870632766014911,0.0008284113975773755
NCT01741506,Coagulation Profile in Patients Undergoing Video Assisted Thorascopic Surgery (VATS) for Lung Cancer,0.0005812640789650476,0.0005282927315593666
NCT01737112,99mTc-3PRGD2 SPECT/CT in Lung Cancer Patients,0.0007269624344156722,0.0005969276198424214
NCT01789892,Methylprednisolone Before Fludeoxyglucose-Labeled Positron Emission Tomography in Patients With Lung Cancer,0.0005951679411048739,0.0005724137968432697
NCT01721759,Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens,0.000827687001756381,0.0007305278227693733
NCT01749072,Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients,0.0007106964869693806,0.0006900103569550802
NCT01724801,Icotinib or Whole Brain Irradiation in EGFR-mutant Lung Cancer,0.0006981459417748227,0.0005332264066264248
NCT01743586,Respiratory Muscle Function Changes and Effects of Chest Physiotherapy Education Interventionin Advanced Lung Cancer,0.00047286371961440687,0.0005160192967294721
NCT01771796,Training Effects Following Resection Surgery in Patients With Lung Cancer,0.0006571029232236994,0.0005898737314769777
NCT01778920,Pilot and Feasibility Study of the Imaging Potential of EC17: Intraoperative Folate-fluorescein Conjugate (EC17) Lung Cancer (CA),0.00043962924261729645,0.0006647264642819536
NCT01708954,Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer,0.0007415866139544526,0.0008336219248110611
NCT01797913,The Study of Gemcitabine in the Maintenance Treatment of Advanced Non-small Cell Lung Cancer,0.0007617928075640434,0.0010686533076396498
NCT01799980,Evaluation of Endobronchial Ultrasound (EBUS) for Staging Lung Cancer,0.000661116271590375,0.0005580386560776927
NCT01799395,Prevalence and Incidence of Central Airway Obstruction in Advanced Lung Cancer,0.0006052163421058684,0.0005190885982991462
NCT01720186,Evaluation of a Pneumotachograph (SPI) for the Production of PET and CT Acquisitions Synchronized With Breath for the Assessment of Extension of Lung Cancer,0.0004439036344177951,0.0005022890711187358
NCT01720836,Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer,0.0006393709869218602,0.0006257965166493829
NCT01772797,Phase Ib Study of LDK378 and AUY922 in ALK-rearranged Non-small Cell Lung Cancer,0.0010532469033602801,0.0009399377147098964
NCT01796288,The Value of Radiotherapy in the Oligometastatic Non-squamous Non-small Cell Lung Cancer With Clinical Benefits From Erlotinib as Second-line Treatment,0.0006427066569655278,0.0007383136453371386
NCT01763671,Paclitaxel-bevacizumab in Advanced Lung Cancer,0.0006344736049046485,0.0006209796904433569
NCT01793155,"Effects of Inspiratory Muscle Training After Lung Cancer Surgery, a Randomized Controlled Trial",0.00045319752192558675,0.0004940029822414204
NCT01705184,Re-introduction of Pemetrexed and Cisplatin With Prolonged Angiogenic Blocking by Bevacizumab in Advanced Lung Cancer.,0.0004903485294934501,0.00043852856373758026
NCT01757158,Cesium-131 Seed Brachytherapy Plus Subtotal Resection for Lung Cancer Patients,0.0005851240958737629,0.0007609186490114768
NCT01781741,Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Stage III-IV Non-small Cell Lung Cancer,0.0007676693744197836,0.0007594221359994076
NCT01781988,Personalized Therapy in Non-small Cell Lung Cancer,0.0009792117667445652,0.0006504413656236053
NCT01714037,A Clinical Study on the Safety and Efficacy of Debio 0932 in Combination With Standard of Care in Patients With Non-small Cell Lung Cancer [NSCLC],0.0007955129286324404,0.0008161399567776804
NCT01786590,Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients With Non-small Cell Lung Cancer Pursuing Stereotactic Body Radiotherapy (SBRT),0.0006941949215193421,0.0005611694901139826
NCT01782287,Proteome-based Immunotherapy of Lung Cancer Brain Metastases,0.0006553449119358584,0.0004731158596087886
NCT01717482,Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer,0.0006380427172369336,0.0007535085689316511
NCT01745484,Role of SPECT in Radiotherapy of Lung Cancer and Toxicity Evaluation,0.0004784784138906358,0.0006301562778164599
NCT02841228,Intensity-modulated Radiotherapy (IMRT) With Simultaneous Integrated Boost (SIB) for Inoperable Non-small-cell Lung Cancer,0.000983173372920729,0.0005010147804259743
NCT02895503,Yoga in Improving Quality of Life in Patients With Non-small Cell Lung Cancer Undergoing Treatment,0.0007768104083476921,0.0009007667372614983
NCT02855281,Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer,0.0007342794052969822,0.0006451688833090458
NCT02877966,Evaluation of the Effects of a Mixture of Amino Acids (Amixea) on Lean Body Mass and Muscle Strengh of Patients With Unresectable Advanced Non-small Cell Lung Cancer,0.0007501724453706901,0.0007584885164365486
NCT02817945,Dual Integrin αvβ3 and SSTR2 Targeting PET Imaging in Lung Cancer Patients,0.000648370700403658,0.0006266052803796087
NCT02844140,DE-CT in Lung Cancer Proton Therapy,0.0009033751975948812,0.0008759830040787682
NCT02879617,A Clinical Trial of Durvalumab (MEDI4736) as 1st Line Therapy in Advanced Non-small Cell Lung Cancer Patients,0.0007810122125438052,0.000668033283738772
NCT02875340,A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer,0.0008821185345845641,0.0009704945284609973
NCT02804776,PRe-Operative Gefitinib in Resectable EGFR Mutation Positive Lung Cancer With Sector Sequencing for Biomarker Discovery,0.00048434559431061907,0.0005767189326165638
NCT02840227,The Effect of Combined General/Regional Anesthesia on Cancer Recurrence in Patients Having Lung Cancer Resections,0.0005697230440088541,0.0005510695852241117
NCT02802540,"Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients",0.0005880558486912752,0.0006164455064992386
NCT02894853,Lung Cancer Early Molecular Assessment Trial,0.0006484335525461151,0.0006016289747295736
NCT02888743,Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer,0.0007324291418396772,0.0007569197855211468
NCT02887521,Pulmonary Rehabilitation Before Lung Cancer Resection,0.0006469131141080002,0.0004646338627414751
NCT02869685,Clinical Research for the Consistency Analysis of PD-L1 in Lung Cancer Tissue and Plasma Exosome Before and After Radiotherapy,0.000474149180742192,0.000515419237337496
NCT02848872,Evaluation of Tumor and Blood Immune Biomarkers in Resected Non-small Cell Lung Cancer,0.000589112042374839,0.0006154280935615989
NCT02803619,A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis,0.0007704291918728707,0.0007990962607270361
NCT02803333,Oncology Research Information Exchange Network (ORIEN) Lung Cancer Study,0.0005599996689290426,0.000561412117972467
NCT02803203,Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers,0.0005779118362293227,0.0006763675965612275
NCT02835690,"Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Pembrolizumab (MK-3475) in Chinese Participants With Non-Small-Cell Lung Cancer (MK-3475-032/KEYNOTE-032)",0.0007272613962677958,0.0010136880127900115
NCT02801409,Epidural Anesthesia/Analgesia and Outcome of Patients After Lung Cancer Surgery,0.0006524556758027463,0.0005955071052730489
NCT02801734,Enhancing Quality of Life in Patients (EQUIP) Intervention for Patients With Advanced Lung Cancer,0.0006527933981538929,0.0006349113082706135
NCT02846792,"Nivolumab and Plinabulin in Treating Patients With Stage IIIB-IV, Recurrent, or Metastatic Non-small Cell Lung Cancer",0.0007525625895024025,0.0008454484517963416
NCT02846103,Study of Anti-telomerase T CD4 Immunity in Metastatic Lung Cancer,0.0006518626633220967,0.0006262237058757926
NCT02831959,Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS),0.0007363917619211046,0.000734069798526871
NCT02827357,Responses to Chemotherapy of Patients With Non-small Cell Lung Cancer Harboring a Known Somatic Activating HER2 Mutation,0.0008390504286515613,0.0006371277002047399
NCT02827344,PDL-1 Expression on Circulating Tumor Cells in Non-small Cell Lung Cancer,0.0007392843624336167,0.0006472861912778729
NCT02898116,"A Study of ALK Inhibitor, Ensartinib, and Anti-PD-L1, Durvalumab, in Subjects With ALK-rearranged Non-small Cell Lung Cancer",0.0006641933010932115,0.0006036821210700129
NCT02839265,FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung Cancer,0.0006514086175940215,0.0006543258121525692
NCT02839629,Long-term Epidemiological Follow-up of Non-small Cell Lung Cancer in Scandinavia,0.001319625915519793,0.001008310734606518
NCT02897765,"A Personalized Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer",0.0005902770716536426,0.0007085115346239257
NCT02821936,Parametric Imaging in Positron Emission Tomography for Patient With Lung Cancer,0.0006480673584230881,0.0006413092735968792
NCT02821949,Evaluation of Serum Procalcitonin Rate in Patients With Stage IV Non-small Cell Lung Cancer in First Line Chemotherapy,0.0007296270333230668,0.0008042009968428057
NCT02845856,Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung Cancer,0.0006637307694827193,0.0009080454271428528
NCT02809456,"Mitigation of Radiation Pneumonitis, Fibrosis and Heart Toxicity With Nicorandil in Lung Cancer Patients",0.0005537068209582938,0.0006180737455379103
NCT02810457,Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer,0.0008110188017420247,0.001079048920464972
NCT02810262,Association of Bone and Metabolic Parameters With Overall Survival in Patients With Bone Metastases From Adenocarcinoma Lung Cancer (POUMOS),0.0005498674779145367,0.00047416882634567094
NCT02873416,Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer,0.0007364693059136276,0.0005832680137680394
NCT02853006,Study on Fluids Associated to Lung Cancer,0.0007748233877948422,0.00047477253375744047
NCT02853188,Measure of Plasma Tissue Factor to Predict a Venous Thromboembolism in Primitive Cancer of Lung,0.0005292355811609449,0.0005968096304624422
NCT02856581,Smoking Cessation Prior to Surgery to Reduce Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes,0.0005897815975019723,0.0005530122594613752
NCT02822209,"Evaluation of the Impact of a Coordinating Nurse in a Personalized Care Program on Quality of Care, Coordination of the Actors and on Quality of Life for Patients With Lung Cancer",0.0005768756265393532,0.0005449042942989794
NCT02824458,A Study of Gefitinib With or Without Apatinib in Patients With Advanced Non-squamous Non-Small-Cell Lung Cancer Harboring EGFR Mutations,0.0008374195524829786,0.000816610434478329
NCT02823990,TG4010 and Nivolumab in Patients With Lung Cancer,0.000915656033327745,0.0007049967060437222
NCT03101579,Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung Cancer,0.0007448980875484681,0.0007229281012315767
NCT01574300,Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network,0.0005673595610226223,0.0006660695702271653
NCT01579188,Study of the Telomerase Vaccine GV1001 to Treat Patients With Inoperable Stage III Non-small Cell Lung Cancer,0.0008248558827981102,0.0008592574516034795
NCT01579994,Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers,0.0005247093266668472,0.0005561935368762484
NCT01592617,Phase II Study of S-488410 to Treat Non-small Cell Lung Cancer,0.0008351855997263207,0.0006990924003426867
NCT01580332,Non-Invasive Biomarkers For Early Detection Of Lung Cancers,0.0005373519967588775,0.0005009608811930736
NCT01580735,ARQ 197 Plus Erlotinib in Patient With Locally Advanced or Metastatic EGFR Mutation-positive Non-small-cell Lung Cancer,0.0006852695046824269,0.0007436927575114818
NCT01580982,Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer,0.0005264616510515728,0.00045113061245332314
NCT01580579,Predictors of Radiation Pneumonitis in Locally Advanced Lung Cancer Treated With Chemoradiation,0.0006094069850594045,0.00044872549137466803
NCT01560104,A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer,0.000844600590277989,0.0007477776121889682
NCT01560195,A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy,0.0008507496390274834,0.0007231304866182551
NCT01577212,Individualized Dose Prescription in Advanced Stage Lung Cancer Patients Using Modern (Chemo)Radiotherapy,0.0007326252845359984,0.0007485353871595892
NCT01551251,Tumor Associated Macrophage in Advanced Non-small Cell Lung Cancer,0.0007169525751500858,0.0008482598824553434
NCT01537991,ISoToxic Accelerated RadioTherapy in Locally Advanced Non-small Cell Lung Cancer: The Phase I/II I-START Trial,0.0008168718932498786,0.0009362869267277005
NCT01515969,Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC),0.0006893258639706835,0.0007251544774074916
NCT01585675,Specimen Banking From Patients With Lung Cancer,0.0009098556342462879,0.000507427298496873
NCT01585883,Self-Management Intervention for Breathlessness in Lung Cancer,0.0005288199443183994,0.0006568937209444586
NCT01555502,Health Related Quality of Life After Video Assisted Thoracoscopic Lobectomy for Lung Cancer,0.00042773471401163094,0.00047219009026597513
NCT01507428,Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer,0.0008046799692232199,0.0008016047956637487
NCT01562015,A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC),0.0006906939482582199,0.0006751877281154083
NCT01578018,Tumor Markers in Lung Cancer: DCAMLK-1LK-1,0.0006748358283762872,0.00046330174277770566
NCT01546233,Multidisciplinary Education in Lung Cancer Patients Who Receiving Chemotherapy Treatment,0.0006991887554628389,0.0007114960033892387
NCT01529112,"A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different Treatments",0.0007239010111727158,0.0008297875907309159
NCT01565980,Mindfulness Therapy for Individuals With Lung Cancer,0.000700378131575101,0.0006617475878851858
NCT01500876,A Feasibility Study Using Four-Dimensional CT Imaging for Primary Lung Cancer,0.0005290300871031518,0.0005394174335840247
NCT01527058,68Ga-BNOTA-PRGD2 PET/CT in Healthy Volunteers and Lung Cancer Patients,0.0007378503019406991,0.00052910373466949
NCT01527461,Identifying Unique Scent Signature of Lung Cancer Through Body Odor,0.0006404633525370686,0.000574771683897812
NCT01527864,Paclitaxel-Carboplatin Alone or With M2ES for Non-Small-Cell Lung Cancer,0.0006722028290702713,0.0005909915485812367
NCT01576796,Radiotherapy Dose Complement in the Treatment of Hypoxic Lesions Patients With Stage III Non-small-cell Lung Cancer,0.0006181504738477411,0.0006141104155313688
NCT01533233,Thoracoscopic Lobectomy Using Nonintubated Anesthesia Versus Intubated General Anesthesia for Lung Cancer Patients,0.0005650172596574252,0.0006059227602364178
NCT01581346,Exercise Study in Patients With Lung Cancer,0.0008303348686118109,0.0006490572352745944
NCT01556191,Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR,0.000640448581293226,0.0006381014168658602
NCT01503385,Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer (NSCLC),0.0007914502517134465,0.000812306314220908
NCT01539928,Dual PET/CT Imaging in Lung Cancer,0.0005398521532543087,0.0004223153239083042
NCT01532089,Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations,0.0007250002060906227,0.00081165006207296
NCT01532362,Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung Cancer,0.0007215794253769516,0.0006540240908268706
NCT02237183,Iloprost in Preventing Lung Cancer in Former Smokers,0.0006465107308652851,0.0005294011804228893
NCT02202655,Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer,0.0008006940978525472,0.0009452902759776485
NCT02223611,Clinical Observation of S1 Capsule for Stage Ⅱ-ⅢA Non-small Cell Lung Cancer After Complete Resection,0.0006151108954840165,0.000800459899058088
NCT02299505,Pharmacokinetic and Safety Study of Lower Doses of Ceritinib Taken With a Low-fat Meal Versus 750 mg of Ceritinib in the Fasted State in Adult Patients With (ALK-positive) Metastatic Non-small Cell Lung Cancer (NSCLC),0.0007944355508940199,0.00072843995954594
NCT02221739,Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC),0.0007062634878554424,0.000787563635923688
NCT02274025,NovellusDx Functional Profiling of Oncogenic Mutations in Lung Cancer Patients,0.0007278894041103494,0.00045432182180386735
NCT02271581,Effect of Symptom Management on Inflammation and Survival in Metastatic Lung Cancer,0.0005516760974111973,0.0004979548357221727
NCT02209727,Single Dose Escalation Study of 131I-Sibrotuzumab in Patients With Advanced or Metastatic Non-small Cell Lung Cancer,0.0008517665170303611,0.0008357851138693368
NCT02222194,The Value of Surgical Mediastinal Staging in Clinical N1 Lung Cancer,0.0004901778467651775,0.0005042383919879712
NCT02272127,Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer,0.0006652306938144176,0.0006983757796748996
NCT02272413,Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer,0.0007622955033859097,0.0006961371209227804
NCT02215356,Icotinib With Concurrent Radiotherapy Versus Chemotherapy With Concurrent Radiotherapy in Non-small Cell Lung Cancer,0.0008078555009950209,0.0007584805305148272
NCT02204059,Biodistribution Study With 186 Re-labelled Humanised Monoclonal Antibody BIWA 4 in Patients With Non-small Cell Lung Cancer,0.0008147350333209582,0.0008545346433771782
NCT02204345,A Study Evaluating RO5479599 in Combination With Carboplatin and Paclitaxel in Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) of Squamous Histology,0.0007440001864749621,0.0007050678769296212
NCT02276027,"A Phase II, Open Label, Multiple Arm Study of AUY922, BYL719, INC280, LDK378 and MEK162 in Chinese Patients With Advanced Non-small Cell Lung Cancer",0.0008327035824955062,0.0009276312909659532
NCT02243748,Palliative Care Intervention in Improving Symptom Control and Quality of Life in Patients With Stage II-IV Non-small Cell Lung Cancer and Their Family Caregivers,0.0006963263718272549,0.0006649215622458028
NCT02206334,"Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer",0.0007415181586209894,0.0007328660873964359
NCT02262325,Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery,0.0007619351509820916,0.0009093156509738831
NCT02211833,Dose Escalation Study of BI 2536 With Pemetrexed in Previously Treated Patients With Non-small-cell Lung Cancer,0.0008402839972723437,0.0010108807366442315
NCT02297425,A Study For Patients With EGFRm (Epidermal Growth Factor Receptor Mutant) Lung Cancer,0.0008320512110039262,0.0005866196840879787
NCT02201992,Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial),0.0007679740208586438,0.0008295064468825223
NCT02296125,AZD9291 Versus Gefitinib or Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer,0.0007968866142507475,0.000690330453838631
NCT02220894,Study of MK-3475 (Pembrolizumab) Versus Platinum-based Chemotherapy for Participants With PD-L1-positive Advanced or Metastatic Non-small Cell Lung Cancer (MK-3475-042/KEYNOTE-042),0.0007188051827685172,0.0008202743205396777
NCT02277457,"Personalized Adaptive Radiation Therapy With Individualized Systemic Targeted Therapy (PARTIST) for Locally Advanced, Non-small Cell Lung Cancer With Genomic Driver Mutations",0.0006772767535210993,0.0006615569330527315
NCT02250326,"Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer",0.0007351434370868648,0.0008419832466312308
NCT02250378,Stereotactic Radiosurgery Followed by Wedge Resection in Treating Patients With Early Stage Peripheral Non-small Cell Lung Cancer,0.000767409617715228,0.0007632113026765251
NCT02245100,Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer,0.0007342079331081826,0.0008662796040976651
NCT02273336,Comprehensive Genomic Analysis in Tissue and Blood Samples From Young Patients With Lung Cancer,0.0007353230524093194,0.0007829519816741234
NCT02208843,Afatinib as Second-line Therapy for Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation,0.0007050330559071373,0.0006260125524592088
NCT02231164,LUME-Columbus: Nintedanib Plus Docetaxel in Advanced Non-small Cell Lung Cancer With Translational Research,0.0006585791744351513,0.0005592613892973032
NCT02292550,Study of Safety and Efficacy of LEE011 and Ceritinib in Patients With ALK-positive Non-small Cell Lung Cancer.,0.0008200126701856254,0.0008955936534044878
NCT02284633,Blood Sample Monitoring of Patients With EGFR Mutated Lung Cancer,0.0007273789053867878,0.000704649801595253
NCT00590902,"Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer",0.0006651707960084561,0.000744739979857115
NCT00532155,A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer,0.0008327759015315978,0.0008352784377852712
NCT00570401,Dasatinib in Treating Patients With Advanced Lung Cancer That Is No Longer Responding to Erlotinib or Gefitinib,0.0006642313870407371,0.0006605619537598587
NCT00531076,Safety Study of Bevacizumab (Avastin) With Thoracic Radiation in Non-small Cell Cell Lung Cancer,0.0006712845626683637,0.0006850468599255777
NCT00516022,"Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination.",0.0006987060229471589,0.0008015395137945285
NCT00563420,Early Lung Cancer Detection in Patients With Sputum Cytology and Autofluorescence Bronchoscopy in People at High Risk of Lung Cancer,0.0005689073114570619,0.0005272784838129594
NCT00563160,Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery,0.0005469169984141279,0.0005537600698636633
NCT00517790,Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC),0.0008219878750528772,0.0011470546690316315
NCT00540280,Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer,0.0006023700717359966,0.0007450995620543074
NCT00545948,Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer,0.0005971566797168797,0.0009029784009099756
NCT00547105,Erlotinib and Stereotactic Body Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Non-Small Call Lung Cancer,0.0006524097915461961,0.0006002956318327523
NCT00509457,GV 1001 Immunotherapy in Patients With Non-small Cell Lung Cancer (NSCLC),0.000842419360297714,0.000570738079938483
NCT00569114,Phase 1 Study of TG01 and Erlotinib in Non-small Cell Lung Cancer (NCSLC) Patients,0.0009082152566316499,0.0009768613714116736
NCT00569712,Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol,0.0005617445299352213,0.0004553376214911381
NCT00586937,Quality of Life in Lung Cancer Survivors,0.0009098586845770279,0.00047389271625400024
NCT00553254,Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer,0.0010194857367323673,0.0014526152027857587
NCT00559065,A Case-Cohort Study of Hematopoietic Malignancies and Related Disorders and Lung Cancer in Benzene-Exposed Workers in China,0.0005128857504226426,0.000584722191426887
NCT00582348,Physical Activity and Inactivity in Lung Cancer Survivors,0.0006492410364539826,0.0006150938426850203
NCT00508144,Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer,0.0005901958217730632,0.0006151112728455069
NCT00556647,Fast-track Diagnosis for Lung Cancer Suspects With PET-CT and EUS,0.0005440387868961629,0.0007126864150688704
NCT00522938,Clinical Trial of the Safety and Effectiveness of CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer,0.0007775935102115798,0.0008690858334375637
NCT00522639,Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation,0.0006176437004894329,0.0006593359092533507
NCT00522197,ACAPHA in Preventing Lung Cancer in Former Smokers With Bronchial Intraepithelial Neoplasia,0.0006461167806626935,0.00048675918063510206
NCT00578084,Lung Cancer Location: a Repository,0.0009021799653660135,0.00046203238257852585
NCT00519805,Dalteparin in Preventing Blood Clots in Patients With Lung Cancer,0.0007254864467442191,0.0005770028833547115
NCT00585377,"Bevacizumab (Avastin®) + Erlotinib as First-line Therapy for Stage IIIB/IV or Recurrent, Non-squamous Cell Lung Cancer",0.0006419611225034867,0.0006604211907369526
NCT00588835,Pharmacokinetic Study on the Addition of Aprepitant to Cisplatin - Etoposide Treatment in Lung Cancer Patients,0.0006633518289968041,0.0007382975319575296
NCT00530621,Study of Enzastaurin Versus Placebo With Pemetrexed for Patients With Advanced or Metastatic Lung Cancer,0.000702224933827173,0.0007463583005750658
NCT00597636,Genetic Susceptibility to Lung Cancer in Never Smokers,0.0005308106534379586,0.00046388805615768416
NCT00506467,Vibration Response Imaging (VRI) in Lung Cancer Patients,0.0009086593654929983,0.0005234277241806262
NCT00568282,Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients,0.0006368904149582,0.0008457832981636716
NCT00568490,Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers,0.0005757825426640465,0.0005882511946775073
NCT00579215,Lung Cancer Informational Study (LCIS),0.0006237883962560012,0.0006002641129858534
NCT00579462,Methylated Genes in Blood as Biomarkers for Advanced Lung Cancer,0.00054448463701059,0.0006504088668979606
NCT00579683,Registry for Patients With Acquired Resistance to Small Molecule Kinase Inhibitors in Non-Small-Cell Lung Cancer,0.0007096565629371766,0.0006245969520451975
NCT00512642,Fluorescence Bronchoscopy and Molecular Characterization of Abnormal Bronchial Lesions: Novel Approaches for Early Detection of Lung Cancer in High Risk Patients,0.0005552475099457081,0.0006584519128280235
NCT00527982,Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer,0.0006342491318538853,0.0005389288809882051
NCT00504374,Gene Polymorphisms and Symptoms in Lung Cancer Patients,0.0009113939360423788,0.0006687670330230008
NCT00503958,Liverpool Lung Project: Risk Factors and Genetic Markers in Healthy Participants and Patients With Lung Cancer,0.0005791779142596332,0.0005693164116857694
NCT00583830,A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer,0.0006757630224763289,0.0008544509995943211
NCT00514215,Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer,0.0006336569987789194,0.0005949899385460584
NCT00538681,"Study for Patients With Advanced, Not Amenable to Surgery, or Metastatic Lung Cancer Comparing Treatment With Pemetrexed + Cisplatin + Enzastaurin Versus Pemetrexed + Cisplatin + Placebo",0.0007457148621905683,0.000762403457924499
NCT00576914,Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer,0.0007228804144752667,0.0007197960782311402
NCT02786589,Plasmodium Immunotherapy for Lung Cancer,0.0006455574479600815,0.0006950151360444434
NCT02715102,Circulating Tumor DNA in Patients at High Risk for Lung Cancer,0.0007430040308801317,0.000570770885689495
NCT02731001,Proton Therapy to Reduce Acute Normal Tissue Toxicity in Locally Advanced Non-small-cell Lung Cancer,0.00048210542975471557,0.000554049004675686
NCT02710565,Use of EBUS TBNA for Cell Culture as an Aid to Diagnose Lung Cancer and Lymphoma,0.0005319839322894517,0.00034310834547098635
NCT02743923,Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer,0.0006584911264925308,0.0007588876422840326
NCT02734524,A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer,0.0006506034020659898,0.0007800074922399646
NCT02713867,"A Dose Frequency Optimization,Trial of Nivolumab 240 mg Every 2 Weeks vs Nivolumab 480 mg Every 4 Weeks in Subjects With Advanced or Metastatic Non-small Cell Lung Cancer Who Received Up to 12 Months of Nivolumab at 3 mg/kg or 240 mg Every 2 Weeks",0.0006419703572736526,0.0007417080867240814
NCT02701699,18F-Fluoroazomycin Arabinoside (18F-FAZA) in Lung Cancer,0.0009021799653660135,0.0007166584163263847
NCT02701231,Low-frequency Rotating Magnetic System Combined With Systemic Anti-tumor Therapy for Advanced Lung Cancer,0.0005409826669953657,0.0009414975349719671
NCT02740894,Can Epidermal Growth Factor Receptor Improve the Postoperative Survivorship for Inoperable Non-small Cell Lung Cancer With Spinal Metastasis ?,0.0005921710316805772,0.0006566476773631725
NCT02754882,A Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung Cancer,0.0008762090881426455,0.0008872711501484658
NCT02754388,Early Detection of Lung Cancer With Low-dose Multislice Computed Tomography,0.0005265847553690454,0.0004467019235087088
NCT02716051,Wholebody MRI In Lung Cancer StagiNg,0.0017222839564628085,0.0005081975104658567
NCT02716311,Combination of Cetuximab With Afatinib for Patient With EGFR Mutated Lung Cancer,0.0006592914085678588,0.0007312516908919332
NCT02736643,Retrospective Epidemiological Study of Lung Cancer With Low-dose Multislice Computed Tomography,0.0006264621090056342,0.00046890043941913824
NCT02789345,A Study of Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib in Participants With Lung Cancer,0.000625639387467127,0.0009315655426213043
NCT02758678,Analysis of P-Selectin Expression on Platelets of Blood From Lung Cancer Patients,0.0005901243164703847,0.0005262009323054396
NCT02732834,Doctor-Patient Communication in Lung Cancer Care,0.0013051624920591663,0.0007213120391345023
NCT02781857,Mass Spectral Fingerprinting in Lung Cancer,0.0009021799653660135,0.0005516696394421679
NCT02720614,Hypofractionated Radiation Therapy Combined With Concurrent Chemotherapy for Patients With Non-small Cell Lung Cancer,0.0008353580110203055,0.0008788436383836577
NCT02730247,Clinical Trial of the Safety and Efficacy of the Addition of Ramucirumab to Nab-paclitaxel in Previously Treated Patients With Advanced Non-small Cell Lung Cancer (NSCLC),0.0007885556299400502,0.0007977288531564328
NCT02771470,Intestinal Microflora in Lung Cancer After Chemotherapy,0.0006847201964725374,0.000617282732935461
NCT02771756,The Effect of Zhen Qi Shen Capsule Combined With Yu Yi Kang on Breast Cancer and Lung Cancer Patients With Chemotherapy,0.0006628285764903676,0.000768701935987801
NCT02726633,Evaluate the Utility of the ProLung China Test in the Diagnosis of Lung Cancer,0.0005487747580417755,0.0009356253380946792
NCT02705404,A Clinical Test for the Treatment of Multifocal Lung Cancers Using Genome Sequencing,0.00047439553471183575,0.00042666942375599987
NCT02705339,Rociletinib Genomic Landscape in Non-small Cell Lung Cancer (NSCLC),0.000772975491561502,0.0005948906223257141
NCT02780778,Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer,0.0007895067186922922,0.0008886736930032948
NCT02733107,The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer,0.000708286509196889,0.0005942822991193509
NCT02708667,An Observational Research Of Crizotinib's Hepatic Toxicity In Non-small Cell Lung Cancer Patients,0.0007098757248795065,0.0006758188315696286
NCT02777788,Curative Study of Chinese Traditional Medicine to Treat Lung Cancer,0.0007764055057698471,0.0009053368735932126
NCT02773238,FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging,0.0007505317499006932,0.0008228083598806168
NCT02737774,Alternating Icotinib and Chemotherapy for Advanced Non-small Cell Lung Cancer With EGFR Mutation,0.0008504723920528405,0.001061287246747588
NCT02751385,Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer,0.0007118604277719245,0.0006040312463292206
NCT02770014,Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer,0.00048110366878410305,0.0006888250830852987
NCT02718651,Blood-based Identification and Monitoring of Patients With ALK-translocated Lung Cancer,0.0006384016234706897,0.0007853505356214825
NCT02793856,PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer,0.0007649949370570388,0.000993846355718116
NCT02764606,CANPOS: Predictive Biomarkers of Tumor Progression in Non-small Cell Lung Cancer,0.0007452282048369453,0.0006829008128839505
NCT02764866,Sleep Apnea in Lung Cancer: A Prospective Study,0.0007740285035663153,0.0008087263241400213
NCT02764086,INTENSE: A Phase I/II Study of INhomogeneous Targeted Dose Escalation in Non-Small CEll Lung Cancer,0.0011026363996239049,0.0006424318550281968
NCT02755454,Perfusion CT Imaging in Lung Cancer With SBRT,0.0006498286626264831,0.0006236372943656679
NCT02755675,"uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung",0.0007174186355976692,0.0007240057447578803
NCT02755337,The Evaluation of Lung Cancer Patient Treated With Epidermal Growth Factor Receptor Tyrosine Kinase,0.0006475995664269806,0.000700961134052558
NCT02755883,Strides for Life I: Increasing Physical Activity in Stage 1 Lung Cancer Patients,0.000638835784659756,0.0005102740878259378
NCT02775435,A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407),0.0006838543211255682,0.0007798791319664005
NCT02759679,Canine-Assisted Profiling of Lung Cancer From Human Breath,0.0006428940965154527,0.0005607598636987654
NCT02738593,Detection Cell Free DNA in Lung Cancer Patients,0.0009436447994994269,0.0006115788015291355
NCT02738684,A Study to Predict Gefitinib' s Efficacy for Lung Cancer by Plasma Free Nucleic Acids EGFR Gene Mutation Test,0.0005553669097016099,0.0005684974177341076
NCT02745002,Navigated EBUS and Functional Imaging in Lung Cancer,0.0009021799653660135,0.00042253511399011886
NCT03070626,Preoperative Loading With Carbohydrates in Lung Cancer Surgery,0.0006717785110183444,0.0005170354305236482
NCT03091491,Study of Nivolumab Verses Nivolumab and Ipilimumab Combination in EGFR Mutant Non-small Cell Lung Cancer,0.0006858099272698541,0.0006923517480952883
NCT03091816,"Dynamic Perfusion Computed Tomography Changes Before, During, and After Stereotactic Body Radiation Therapy in Patients With Localized Non-small Cell Lung Cancer",0.0007114354501961388,0.0007182230852377401
NCT03014648,Evaluating the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer (NSCLC),0.0007376170022809637,0.0005182812601705473
NCT03084692,Therapeutic Yoga and Resistance Exercise for Lung Cancer,0.0005058673567725204,0.0005190816321180954
NCT03089125,Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer,0.000702645202705362,0.0009575126755594267
NCT03077854,Image-Guided Functional Lung Avoidance Thoracic Radiotherapy for Lung Cancer: A Single-Blind Randomized Trial,0.0004482645008627402,0.0005151860292895633
NCT03092739,A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens,0.0005512463434916929,0.0007826568135356348
NCT03092986,Outcome of Cisplatin and Vinblastine Versus Paclitaxel and Carboplatin as Sequential Chemotherapy Followed by Radiotherapy in Locally Advanced Non-small Cell Lung Cancer,0.0006821597227152468,0.0006680974481568307
NCT03087708,Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer,0.0008381403556673286,0.0007934351152485733
NCT03048500,Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery,0.0007218125108177897,0.0007998626453654228
NCT03048136,A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung Cancer,0.000710521498599219,0.0007871051338326114
NCT03048760,Magnetic Resonance Imaging (MRI) for the Delineation of Organs At Risk (OAR) and Target Volumes in Lung Cancer Patients,0.0006333297144887009,0.0006676678870603611
NCT03053804,"Clinical Application of MR-PET in Non-small Cell Lung Cancer: Diagnosis, Treatment Outcome, and Prognosis Prediction",0.0006067249270831985,0.0007355877994873159
NCT03053856,Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer Patients,0.0008161769553846827,0.0009366110507549408
NCT03006575,Study of Consolidation Chemotherapy For Locoregional Recurrence Of Non-small Cell Lung Cancer After Surgical Resection,0.0006539604237249838,0.0007215065382895347
NCT03007953,Palliative Care Interventions for Outpatients Newly Diagnosed With Lung Cancer: Phase II,0.0005334656330237685,0.0005401085422276275
NCT03007875,High-activity Natural Killer Immunotherapy for Small Metastases of Non-small Cell Lung Cancer,0.0005975790521806697,0.0008329601972833019
NCT03088930,Evaluating Crizotinib in the Neoadjuvant Setting in Patients With Non-small Cell Lung Cancer,0.0007435443471825318,0.0007850891247211337
NCT03081741,Circulating Tumor DNA in Surgical Lung Cancer Patients,0.0007647074966653947,0.0011823363925581407
NCT03029871,Oncolytic Adenovirus-Mediated Gene Therapy for Lung Cancer,0.0005211183911654761,0.0005979555719369538
NCT03029325,Molecular and Genetic Analysis of Lung Cancer,0.0006424256149733868,0.0005867398814988658
NCT03054038,Afatinib and Necitumumab in Patients With EGFR Mutation Positive Advanced or Metastatic Non-small Cell Lung Cancer,0.0007701321636618722,0.0008044799238721942
NCT03017885,Post Marketing Surveillance of Nintedanib in Indian Patients With Non-small Cell Lung Cancer (NSCLC) After First-line Therapy,0.0007634618851177844,0.0005733524674220601
NCT03017183,Detection of Heterogeneity in Central Lung Cancer - EBUS-TBNA and ctDNA Analysis vs. Endobronchial Forceps Biopsy,0.00043834054000091454,0.0005606150882031281
NCT03095612,Phase 1/2 Trial of Selinexor (KPT-330) With Docetaxel for Non-small Cell Lung Cancer (NSCLC),0.0006805681019539893,0.0007999458122080772
NCT03068663,Microbiota and the Lung Cancer,0.0017222839564628085,0.0006336157825474029
NCT03003468,Pembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Chemotherapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017,0.0005981699623159223,0.0005922004565483505
NCT03003962,A Study of Durvalumab Versus Standard of Care in Advanced Non Small-Cell Lung Cancer,0.0007247270653540014,0.0007085138192341563
NCT03010033,Effect of Pulmonary Rehabilitation on Perioperative Outcomes in Smoker Patients With Lung Cancer,0.0007330651948668466,0.0005638270459468539
NCT03010657,Evaluation of a Food Intake Modification for Lung Cancer Patients,0.0006441350313167202,0.0009296197527090799
NCT03086733,Phase II Lung Metcore - Preoperative Metformin for Lung Cancer,0.0006471608211220969,0.00048537894985781953
NCT03047616,A Pilot Study to Develop Predictive Biomarkers for the Response to Immunotherapy in Lung Cancer,0.0005668697339467934,0.0006882808735624669
NCT03057340,The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of Tcells,0.0006508050611200147,0.000583064046089931
NCT03090737,Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer,0.0007462737533632712,0.0010390224792359761
NCT03090880,Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE),0.0005321099559356226,0.00045251383409767513
NCT03030131,Immune Neoadjuvant Therapy Study of Durvalumab in Early Stage Non-small Cell Lung Cancer,0.0006649382472742492,0.0007673683962108613
NCT03073902,The Correlation of PD-L1 Expression in Non-small Lung Cancer Tissue and Peripheral Blood T Cell and Serum.,0.0005962425224709939,0.0005972361833546428
NCT03083691,BIOLUMA: Biomarkers for Nivolumab and Ipilimumab and Evaluation of the Combination in Lung Cancer,0.00047761726739804127,0.0006193129320796444
NCT03099577,PET/CT-directed Hyperfractionated Radiation Dose Escalation in Stage III Non-small Cell Lung Cancer,0.0006053738076944956,0.0007689747591053859
NCT03009630,ENB Guided RFA for Early-stage Peripheral Lung Cancer,0.0006944434761768902,0.0007569412294843242
NCT03020251,Effects of Preoperative Rehabilitation in Patients Resected for Lung Cancer,0.0007300976348982502,0.000561565381089229
NCT03082300,A Study of ASP8273 in Subjects With Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations,0.0007566715347941782,0.0007496691232440351
NCT03065764,89Zr-labeled Pembrolizumab in Patients With Non-small-cell Lung Cancer,0.0009149006572997433,0.0004699556480145602
NCT00256789,Once Weekly Radiation for Lung Cancer With Chemotherapy,0.0007388952090896774,0.0008978010177515944
NCT00255489,A Phase I Study of ZD1839 and Palliative Thoracic Radiotherapy in Patients With Non-small-cell Lung Cancer,0.0006923475515780426,0.0008070274269321484
NCT00255775,Broccoli Sprout Extract in Preventing Lung Cancer in Smokers,0.0005261584183827287,0.00036179931728876037
NCT00243867,Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer,0.0005857763185522553,0.0006454534149368593
NCT00250848,Lung Cancer Case Registry and Tissue Resource,0.0005295936903567536,0.0005238931476123984
NCT00219297,Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer,0.0008203355151022074,0.0008659912638234459
NCT00251589,A Phase I/II Clinical Trial of Vorinostat in Combination With Erlotinib for Patients With Relapsed/Refractory Non-Small-Cell Lung Cancer (0683-025),0.000723655157781615,0.0007664159466681361
NCT00265200,Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer,0.00047498211403610693,0.0006625915675826221
NCT00264602,Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer,0.0005239627921871128,0.0005337418833891594
NCT00281125,Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer,0.0006760532120121834,0.0005731420958226014
NCT00221169,Role of PET CT in Determining Target Volumes in Radiation Therapy for Lung Cancer,0.0005090382314130349,0.0006761303580119223
NCT00280202,Detection of Genetic Markers of Lung Cancer,0.0005431037077666597,0.00041680928265394027
NCT00214123,Hypofractionated Radiotherapy for Lung Cancer,0.0009039633686667254,0.0004563900271301123
NCT00263731,Metabolomic Analysis of Lung Cancer,0.0017222839564628085,0.0011550165619562452
NCT00260871,Genetic Epidemiological Study of Lung Cancer in Taiwan and Clinical Applications,0.0005569429441332437,0.00048379622108907363
NCT00260598,LIFE-Lung Bronchoscopy in Patients at Risk for Developing Lung Cancer,0.0007321635853637723,0.0007168164013434472
NCT00294190,Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer,0.0008014457034196679,0.0007143999999901258
NCT00294736,A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients With Stage IIIB/IV Non-small Cell Lung Cancer Who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens,0.0007815989088704177,0.0007711388215135631
NCT00246727,Effects of Selected Vegetable and Herb Mix (SV) on Advanced Non-small Cell Lung Cancer,0.0010296830709446312,0.0007583112807021872
NCT00269828,A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.,0.0006454174419269701,0.0006941041628909494
NCT00277329,Study of XL999 in Patients With Non-small Cell Lung Cancer,0.0010398847775535747,0.0007834417010498294
NCT00210080,A Study to Diagnose Lung Cancer by Sputum Cytology (01-312),0.0006349605229510591,0.0006066300644817107
NCT00273494,Neoadjuvant Chemotherapy Plus/Minus Surgery in Non-Small-Cell Lung Cancer (NSCLC) Stage IIIA/N2,0.0006557550327680287,0.0008604968426120471
NCT00268970,Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer,0.0008121462289460077,0.0009824213087918675
NCT00290550,A Phase IIA Study of MK0457 in Patients With Cancer of the Lung (0457-006),0.0010430495691480164,0.0011236718464907045
NCT00290355,Study to Test the Efficacy of the Vaccine GSK 249553 in Treating Non-small-cell Lung Cancer After Tumour Removal by Surgery,0.0005229041816628952,0.0007585911066461295
NCT00226577,Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer.,0.0006762234791597916,0.0007365812482501033
NCT00238602,Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer,0.0004770185041524947,0.0005283886982467419
NCT00238875,A Phase II Study of Stereotactic Body Radiation Therapy in Patients With T1N0M0 Non-small Cell Lung Cancer (JCOG0403),0.0008937182636611393,0.001246702285249329
NCT00266812,Safety and Tolerability of Low-Dose Temozolomide During Whole Brain Radiation in Patients With Cerebral Metastases From Non-Small-Cell Lung Cancer (Study P04071)(TERMINATED),0.0007819684446780009,0.0007779375613386515
NCT00270582,A Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small-Cell Lung Cancer,0.0007280915331516272,0.0008220646030879928
NCT00257179,The Serum Tissue Factor Level in Lung Cancer Patients as a Prognostic Factor,0.0005920784339867179,0.0005484933600236755
NCT00213733,Molecular Assessment of Lymph Nodes in Patients With Resected (Stage I to IIIA) Non-small Cell Lung Cancer,0.0007232470032894147,0.0006687618011818931
NCT02366143,A Phase III Study of MPDL3280A (Anti-PD-L1 Antibody) in Combination With Carboplatin + Paclitaxel With or Without Bevacizumab in Patients With Stage IV Non-squamous Non-small Cell Lung Cancer [IMpower 150],0.0008023086164274255,0.0008835493007651063
NCT02397239,Comparison of Cost-effectiveness of Continuation Maintenance Therapy With Six Cycles of Pemetrexed Versus Pemetrexed Until Disease Progression for Metastatic Non-squamous Non-small-cell Lung Cancer,0.000450908263678213,0.0007942671814807928
NCT02373917,Characterization of Methylation Patterns in Lung Cancer,0.0017222839564628085,0.0007217761262467118
NCT02380196,The Utility of Circulating Tumor Cells as Confirmation of Pathologic Diagnosis in Patients With Suspected Early Stage Non-small Cell Lung Cancer,0.0007421578258335227,0.0008326357786820508
NCT02335944,Study of Safety and Efficacy of EGF816 in Combination With INC280 in Non-small Cell Lung Cancer Patients With EGFR Mutation.,0.0009138234284144089,0.0009354447178372025
NCT02312622,Phase II Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer,0.0005372129164437388,0.0006970392936773867
NCT02332512,Study of Apatinib as 3rd/4th Line Treatment in Patients With Advanced Non-Squamous Non-small Cell Lung Cancer Harboring Wild-type Epidermal Growth Factor Receptor (EGFR),0.0008428351238698975,0.0008412381235647843
NCT02363101,Health Outcomes and Costs (HOC) in Lung Cancer (LC),0.0009021799653660135,0.0006467987037291597
NCT02317016,"Study to Assess the Effect of AZD9291 on the Blood Levels of Rosuvastatin, in Patients With EGFRm+ Non-small Cell Lung Cancer",0.0007790740958923964,0.0007884231067330378
NCT02336061,Evaluation of Gender Differences on the Psychosocial and Economic Impact in Patients With Advanced Non-small Cell Lung Cancer,0.0008091331022376055,0.001053748976213576
NCT02350361,Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance.,0.0004950357601676655,0.0005080524208734134
NCT02362204,Lung Cancer Nurse Model: a Phase II Study,0.0007740285035663153,0.0005725357198683877
NCT02300298,Nintedanib Plus Docetaxel in Japanese Patients With Adenocarcinoma Subtype Non-small Cell Lung Cancer After Failure of First Line Chemotherapy,0.0007266299114422656,0.0006864430335349384
NCT02308865,Early Palliative Care in Metastatic Lung Cancer in Northern France,0.0005509714749703802,0.0003784356024934911
NCT02308020,"A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain",0.0006383519873022787,0.0007545478472230241
NCT02381808,Study on Potential Biomarkers Associated With Clinical Phenotype of EGFR-TKIs in No-small Cell Lung Cancer in China,0.0006779960730967339,0.0006424122444917527
NCT02388074,Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer,0.00046852466742780476,0.00050180198006209
NCT02309567,"Is There Any Relation Between Serum Anti-p53 Antibody and TLG, MTV and SUV as PET Parameters in Lung Cancer Patients?",0.0005649696508628094,0.0007574077320839261
NCT02392728,Virtual Environments in Patients Receiving Treatment for Lung Cancer,0.0009690144325323015,0.000569238132400097
NCT02320617,Application of Diffusion Weighted MRI Versus CT in Evaluation of the Effect of Treating Lung Cancer,0.000537261001492007,0.0005866661413252205
NCT02315053,PET Response During Chemoradiation of Lung Cancer,0.0005428544377728003,0.0006522359584710431
NCT02372448,Multicenter Validation of the Sensitivity of Theranostic ALK Rearrangement Detection by FISH Analysis and Prevalence of Escaping Mutations in Circulating Tumor Cells for the Non-invasive Management of Lung Cancer Patients,0.0005611480827126564,0.0008886900821114082
NCT02358473,Study of Mogamulizumab + Docetaxel in Subjects With Non-small Cell Lung Cancer,0.000733542721173003,0.0008797629830748744
NCT02318771,"Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer",0.000610021320795231,0.0006675610285790098
NCT02318368,"A Phase 2, Multicenter, Study of Ficlatuzumab Plus Erlotinib Versus Placebo Plus Erlotinib in Subjects Who Have Previously Untreated Metastatic, EGFR-mutated Non-small Cell Lung Cancer (NSCLC) and BDX004 Positive Label",0.0006772843551549026,0.0007128987675770122
NCT02323126,Study of Efficacy and Safety of Nivolumab in Combination With EGF816 and of Nivolumab in Combination With INC280 in Patients With Previously Treated Non-small Cell Lung Cancer,0.0008368380758990573,0.0009603008422747634
NCT02364804,A Study to Evaluate the Efficacy of Anti-emetic Drug Upon the Combination Chemotherapy for Non-small Cell Lung Cancer,0.0006503568218668907,0.0007611590084519492
NCT02364609,Pembrolizumab and Afatinib in Patients With Non-small Cell Lung Cancer With Resistance to Erlotinib,0.000726901381433342,0.0007871458042916618
NCT02394548,Phase I Trial Of IMRT Using A Contralateral Esophagus Sparing Technique (CEST) In Locally Advanced Lung Cancer,0.0007508577575397985,0.0005105479191603031
NCT02342353,Pacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI),0.0007316260984060539,0.0007708091671748338
NCT02337712,Once-daily Simultaneous Modulated Accelerated Thoracic Radiotherapy in Limited Small-cell Lung Cancer,0.0005643634410124376,0.0007239717954689897
NCT02331290,Excretion of Acetylamantadine (AA) by Lung Cancer Patients During a Chemotherapy Regimen,0.0007260855592858162,0.0006782817033090928
NCT02348450,Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer,0.0005099336337726659,0.0006071419318621925
NCT02354274,Novel Approach to Radiotherapy in Locally Advanced Lung Cancer - Heterogeneous FDG-guided Dose Escalation With Concomitant Navelbine®,0.0005650794160463344,0.0004478183808385019
NCT02301858,Identification of Predictive and Prognostic Markers for Lung Cancer With Metastases,0.0004793482784060054,0.0004519081377800148
NCT02367794,A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-paclitaxel Compared With Carboplatin + Nab-paclitaxel in Participants With Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) [IMpower 131],0.0006850892278722636,0.0007856300097958883
NCT02393209,Docetaxel With or Without MLN1117 in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer,0.0007399290271993689,0.0008600873458123589
NCT02393625,Study of Safety and Efficacy of Ceritinib in Combination With Nivolumab in Patients With ALK-positive Non-small Cell Lung Cancer,0.0007833307408673508,0.0008080908930995801
NCT02357992,Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy,0.0007396336918385046,0.0007866478653203255
NCT02357836,Neoadjuvant Itraconazole in Non-small Cell Lung Cancer,0.0007357419205896154,0.0009419670141001705
NCT01396551,Evaluating an Anchored Transponder in Lung Cancer Patients Receiving Radiation Therapy,0.0006661123937796756,0.0006558032049972847
NCT01351415,A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC),0.0007438671650783773,0.0007101111852436091
NCT01351116,A Trial to Evaluate the Improvement in Lung Cancer Patients Receiving Radiation With or Without Brachytherapy,0.0006787793899237852,0.0007028299996308978
NCT01312337,Iressa for EGFR Mutation Negative Non-small Cell Lung Cancer (NSCLC),0.0006700823884779117,0.0005429358976197065
NCT01336634,Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination With Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer.,0.0006579660448721579,0.000706188752562905
NCT01336543,Consolidation Chemotherapy/Concurrent Chemo-radiotherapy for Inoperable Stage III Non-small Cell Lung Cancer (NSCLC),0.0006247308664732063,0.0007941833830653506
NCT01336192,Maintenance Gemcitabine in the Chinese Advanced Lung Cancer,0.0007602262378733411,0.000720999942147244
NCT01385111,Combined Application of EBUS and EUS in Lung Cancer,0.0009045928904564526,0.0004839276265304567
NCT01383408,Distinction Between Lung Cancer and Gynecological Cancers by Canine Scent Detection,0.0005338519921588123,0.000520885354650698
NCT01358942,An Observational Study of Lung Cancer Related Symptoms and Disease Control Rate in Patients With Non-Small Cell Lung Cancer Receiving First-Line Platinum-Based Chemotherapy With or Without Avastin (Bevacizumab),0.0006278190424242469,0.000677121209549781
NCT01399541,Recovery and Rehabilitation After Lung Cancer Surgery,0.0005462739565642009,0.00046375865045400114
NCT01325753,Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body,0.0005910786904375536,0.0006726893366929434
NCT01360931,The Roles of Neutrophil Elastase in Lung Cancer,0.0009021799653660135,0.0006020754221225681
NCT01389739,Intervention to Improve Continuity of Care in Lung Cancer Patients,0.0006380423832840192,0.0006361772457757016
NCT01356303,Docetaxel Combined With Cisplatin as First Line in Patients With Metastatic Non-small Cell Lung Cancer,0.0007467788353420451,0.0007747220827212422
NCT01302626,Radiomics: a Study of Outcome in Lung Cancer,0.0011026363996239049,0.0005366992792993308
NCT01386203,Exhaled Breath Biomarkers in Lung Cancer,0.0006586086921872908,0.0006636653613132379
NCT01386385,"Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery",0.0007594569340661618,0.0008840968721089334
NCT01359436,e- Ab Sensor-based Real-time Detection of Mutant EGFR in Clinical Specimens From Patients of Non-small Cell Lung Cancer,0.0007154446387023673,0.0007319560151214289
NCT01310387,Prospective Study of Active Pain Management in Lung Cancer Outpatients (APM),0.0006237861818241134,0.0005137553710750588
NCT01310244,Maximum Tolerated Dose Study of Belinostat (PXD-101)in Combination With Paclitaxel Plus Carboplatin in Chemotherapy-Naive Patients With Stage IV Non-Small-Cell Lung Cancer (NSCLC),0.0008385040254676651,0.0007671543561756512
NCT01337037,Modified Video-assisted Thoracoscopic Surgery (VATS) Lobectomy for Early-stage Non-small Cell Lung Cancer (NSCLC),0.0006054695636477177,0.0008412084873395827
NCT01391260,Radiotherapy Combined With Iressa for EGFR Mutation Positive Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC),0.0008020313237340007,0.0008941709373542779
NCT01342965,A Study of Erlotinib (Tarceva) Versus Gemcitabine/Cisplatin as First-line Treatment in Patients With Non-small Cell Lung Cancer With EGFR Mutations,0.0008071776100130255,0.000794537535793541
NCT01342770,Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer,0.0008381403556673286,0.0009783595988121408
NCT01305967,Investigation of Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer,0.0007896920234412707,0.0009531542167516327
NCT01306188,Prognostic Value of Divpenia and CD4 Count in Relapsed Breast or Lung Cancer Patients,0.0005689648376732061,0.0005853480175300737
NCT01300299,STEREOtactic Radiation and Chemotherapy in Lung Cancer (STEREO),0.0007388952090896774,0.0006922055662021202
NCT01300429,Molecular Determinants of Acquired Clinical Resistance to Crizotinib in Non-small Cell Lung Cancer Harboring a Translocation or Inversion Event Involving the ALK Gene Locus,0.0005593068809399098,0.0005655208035571331
NCT01362842,Psychological and Physical Distress and Care Needs in Operable Lung Cancer Patients Receiving Surgery,0.0006068039171451487,0.0006155830530722195
NCT01362296,An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer,0.0006833387640126831,0.0008232601548721058
NCT01309087,Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: AEGIS CLIA,0.0004729513181118202,0.0005369820320107166
NCT01363557,Assess the Efficacy of Whole Brain Radiation Therapy in Lung Cancer Patients With Brain Metastasis,0.0006754117585716087,0.0006405233949479941
NCT01313663,A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population,0.0006937159523080446,0.0006794658356896866
NCT01394679,A Phase 3 Study of 99mTC-EC-DG SPECT/CT Versus PET/CT in Lung Cancer,0.0005586964271638582,0.0005339799500229049
NCT00887783,Navelbine And Radiotherapy in Locally Advanced Lung Cancer,0.0006460453176855376,0.00070942012506717
NCT00880971,To Evaluate Postoperative 3D Conform Radiotherapy in Patients With IIIA (N2) Non-small Cell Lung Cancer,0.0008523190221392935,0.000690160909220498
NCT00871403,Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer,0.0007319627184643273,0.0009648355408658834
NCT00856427,Implantation of Markers for the Radiotherapy of Lung Cancer Patients,0.0006772751818313259,0.000628014500239081
NCT00898209,Serum and Exhaled Breath Condensate MALDI-MS of Lung Cancer. (SPORE),0.0004661899362601791,0.0004908044421650591
NCT00898313,Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer,0.0006416467981329185,0.0005926567197824563
NCT00884598,Cilengitide and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Lung Cancer,0.0006232237686788583,0.0005233395608708076
NCT00807170,Investigate the Maximum Tolerated Dose of Vandetanib and Concurrent Whole Brain Radiotherapy (WBRT) in Patients With Non-small Cell Lung Cancer (NSCLC) and Brain Metastases,0.0007428231301810335,0.0007437636312526626
NCT00807391,Transbronchial Catheter Aspiration and Transbronchial Needle Aspiration in the Diagnosis of Lung Cancer,0.00047270796206914245,0.0005670195682230178
NCT00831545,"Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)",0.0006393028867350859,0.0007108239195584347
NCT00867412,Randomized Study of Positron Emission Tomography - Computed Tomography (PET/CT) in Pre-Operative Staging of Lung Cancer,0.0005615488201425859,0.0006845897289908783
NCT00818402,Non-small Cell Lung Cancer and Quality of Life,0.0009241682285183121,0.0008109749976058136
NCT00886678,A Study of Pemetrexed Plus Carboplatin Combined With Radiation in Patients With Inoperable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) (RT0801),0.0008750719287229484,0.0008656516548918009
NCT00830245,A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung Cancer,0.0006823976412273014,0.0008228923668174079
NCT00866528,Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung Cancer,0.0007368757384651764,0.000746877473048843
NCT00894127,Sputum Labeling Utilizing Synthetic Meso Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer,0.00046852466742780476,0.0004825381941564084
NCT00852462,Lung Cancer Symptom Assessment and Management Intervention,0.0005280408926615282,0.0005420566759395559
NCT00870532,Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer,0.0008308267115326957,0.0007395075017782227
NCT00870870,A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Patients With Lung Cancer Who Have Not Received Chemotherapy Before,0.0006609611727254757,0.0008720061104301544
NCT00832819,E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC),0.0007728281126263197,0.0008791258972623422
NCT00862173,Gene-expression Profiles in CNS-metastatic Non-small Cell Lung Cancer,0.0006625191661370766,0.0008486286117974958
NCT00874588,Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer,0.0006959599812503614,0.000713431122178644
NCT00855894,A Study of the Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer,0.0007901969275491058,0.0008295516010093695
NCT00897143,Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer,0.0007307711130565499,0.0006068404933179584
NCT00897650,Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer,0.000626285855846015,0.0006938582284670863
NCT00826852,Weekly Docetaxel and Four Weekly Carboplatin in Non-small Cell Lung Cancer Carbo-Tax,0.0006653115366805146,0.0007156790746880263
NCT00826683,Detection of Circulating Endothelial Progenitors Cells (EPCs) in Non-small Cell Lung Cancer (NSCLC),0.0006228301108431628,0.0005864142250002678
NCT00826033,Fluorine-18-α-Methyltyrosine Positron Emission Tomography (18F-FMT PET) for Therapy Response in Lung Cancer,0.0005153166824313171,0.000551778066002147
NCT00865319,Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-small Cell Lung Cancer (NSCLC),0.0007839098233911636,0.0006914232996083517
NCT00888511,Tarceva And Radiotherapy in Locally Advanced Lung Cancer Non-small Cell Lung Cancer,0.0007430151438585498,0.0007488045725994883
NCT00836992,"Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer",0.0006189148286540969,0.0006086124497680553
NCT00858403,Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target Modulation,0.0006624320343954601,0.0008541585022500758
NCT00858520,"Serum, Plasma, DNA and Tissue Bank in Chronic Obstructive Pulmonary Disease and Lung Cancer",0.0004718035994011136,0.00043804004232486453
NCT00820755,Trial With Cetuximab in Maintenance Therapy After Platinum Based Chemotherapy in First Line Treatment of Non-small Cell Lung Cancer (NSCLC),0.0006039693481597055,0.0007315320473434371
NCT00806286,Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer,0.0006842107924972849,0.0007089371852356885
NCT00809237,Hydroxychloroquine and Gefitinib to Treat Lung Cancer,0.0006474571729366836,0.0005538454388882594
NCT00883675,Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer,0.0005883388099877408,0.0007916110056757927
NCT00829322,Modafinil for the Treatment of Fatigue in Lung Cancer V9.0,0.0005679506740810657,0.0005600696109251692
NCT00876460,"BIBF 1120 + Docetaxel (Japan) in Patients With Advanced Non-small-cell Lung Cancer, Phase I",0.0008247376406619809,0.0007506023485727272
NCT00899457,Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants,0.0005401324877977002,0.0003610611332459884
NCT00899262,"Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers",0.0006490892496102306,0.0006100112122677276
NCT00899028,Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants,0.0007442058784552212,0.0006210445353983852
NCT00899782,Collection and Storage of Blood and Tissue Samples From Patients Who Are Undergoing Surgery For Lung Cancer,0.0006104379886282717,0.0006015809985277496
NCT00899405,Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer,0.0006054155080184692,0.0004976797427922296
NCT00840749,Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer,0.0006659397654683064,0.0006617443959355692
NCT00851448,"Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients",0.0006331801214148518,0.0003671133617860664
NCT00819728,Trial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung Cancer,0.0007629853668418965,0.000764662346995997
NCT00864110,Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC),0.0007853969778443499,0.0006534728497759614
NCT01642004,Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017),0.0007285342649341986,0.0008078694468596027
NCT01642251,Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer or Metastatic Large Cell Neuroendocrine Non-small Cell Lung Cancer,0.0007370849572772229,0.0008478841765044482
NCT01687439,Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC),0.000637271405322273,0.0006265896772430739
NCT01687738,Lung Cancer Surgery: Decisions Against Life Saving Care - The Intervention,0.0005518288209112454,0.0007895137548355758
NCT01673711,Deuterated Phenanthrene Tetraol in Smokers Who Are at High Risk For Lung Cancer,0.0005288303494865649,0.0005168413894232086
NCT01620190,Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung Cancer,0.0007558649455453225,0.0007361935316363612
NCT01620853,Detection of Chromosomal Aberrations in Non-small Cell Lung Cancer (NSCLC) Using Fluorescent in Situ Hybridization (FISH) (ALK Test),0.000594920419475619,0.0006792864729948857
NCT01684696,Virtual Intervention for Lung Cancer,0.0009128938022477617,0.00046248872410628437
NCT01647867,Study of the Expression of Met Receptor Fragments in Non Small Cell Lung Cancers,0.0006648885049502518,0.0005892735867600817
NCT01647425,Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer,0.0006334276384870316,0.0008093861529684837
NCT01647711,"A Study of Intermittent, High-dose Afatinib to Determine the Maximal Tolerated Dose and Assess Activity of This Dose Against Non-small Cell Lung Cancer With T790M Mutations",0.0006281564722781657,0.0006828221386185034
NCT01656460,Stereotactic Body Radiation for Consolidation After Standard Chemoradiation for Stage 3 Lung Cancer,0.0004571689954570002,0.0006410697456144608
NCT01610544,18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma,0.000510457347398157,0.0006708743744575351
NCT01688713,Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer,0.0009286588961926608,0.0007219509981430245
NCT01622621,Stereotactic Body Radiotherapy (SBRT) Versus Sublobar Resection for High-Risk Patients Non-Small Lung Cancer,0.0006392790684991952,0.000703411033052312
NCT01668823,Photodynamic Therapy in Treating Patients With Lung Cancer,0.0009098260818223908,0.0006060609455010714
NCT01664533,An Observational Study of Erlotinib (Tarceva) as Second-line Treatment in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Failure of Pemetrexed in First-line Therapy,0.000870627684901782,0.0008786943145403063
NCT01631357,Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer,0.000663034838324968,0.0006673110999279563
NCT01631526,Vitamin D Loading Dose in Advanced Lung Cancer,0.0007508678164957422,0.00037559027509089963
NCT01685346,Biofeedback Training in Patients With Advanced Lung Cancer - A Pilot Study,0.000722249460712313,0.0006598247198814229
NCT01685138,LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer,0.0009405027004662887,0.0008272306988720067
NCT01660087,Diagnosis of Lung Cancer From Exhaled Breath With Silicon Biophotonic Device,0.0005343002509323687,0.00035093245107445354
NCT01661790,Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer,0.0006117482328527468,0.0007281651755403548
NCT01682850,Pulmonary Rehabilitation Before Lung Cancer Resection,0.0006469131141080002,0.0005638077485599306
NCT01648517,Genotype-Driven Treatment of Advanced Non-small Cell Lung Cancer Based on mRNA Expression of ERCC1 & RRM1 as First-line Chemotherapy,0.0006623986983443197,0.0007046563237832155
NCT01648166,A Population-based Case-control Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens,0.0005501362010982212,0.0004481620547667906
NCT01649947,Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II,0.0010209789732092852,0.0007579410840702023
NCT01670539,Home Telemonitoring for Patients With Lung Cancer,0.0009086593654929983,0.0004982574505469708
NCT01617980,Multimodal Hypoxia Imaging and Intensity Modulated Radiotherapy for Inoperable Non-small-cell Lung Cancer,0.00046990594932501504,0.0008166745746759659
NCT01637376,Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer,0.0006403856819236848,0.0007180547386906529
NCT01658332,Circulating Tumor Cells in Lung Cancer,0.0009068680738600622,0.0006758951425762871
NCT01658813,"5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer",0.00044236384384885644,0.0006008216077875851
NCT01624051,A Study Comparing Chemotherapy Dosing Based on Either Standard Body Surface Area or Lean Body Mass in Patients With Advanced Lung Cancer,0.0006938594421581965,0.0006577507892917357
NCT01652820,Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung Cancer,0.0006698287694356944,0.0006960906891911986
NCT01652469,Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®.,0.000586679706611828,0.0005099433720431237
NCT01679743,GRN1005 for Brain Metastases From Breast or Lung Cancer,0.000652197351501013,0.0006395804608394964
NCT01619241,Pilot Study for Evaluating the Role of F-18 FLT PET/CT in Therapeutic Decision Making in Non-small Cell Lung Cancer,0.0006765570870085644,0.0007573458878928209
NCT01619501,Dysregulation of the C/EBPa Pathway in Human Lung Cancer and Search for New Biomarkers and/or Therapeutic Targets,0.000579754986550362,0.0005161317360367952
NCT01037998,UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer,0.0005228840854058733,0.00047395985658692274
NCT01012401,Evaluating an Interactive Cancer Communication System (ICCS) in Lung Cancer,0.0009140256921928923,0.0005786177895339123
NCT01052818,Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer,0.000623830372960717,0.0008169795267517153
NCT01082549,Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC),0.0006011109680530842,0.0005563119347064834
NCT01078883,Respiratory Muscle Performance and Functional Capacity in Primary Stage IIIb and IV Lung Cancer,0.0005629756044492682,0.0005140853621119924
NCT01039311,Optical Coherence Tomography: An Adjunct to Flexible Bronchoscopy in the Diagnosis of Lung Cancer,0.0005335121010209876,0.0004621736447194629
NCT01069575,Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Non-small Cell Lung Cancer,0.0007241081775000221,0.0007016374136418301
NCT01069640,Safety Study of Peptide Cancer Vaccine To Treat HLA-A*02-positive Advanced Non-small Cell Lung Cancer,0.0007241081775000221,0.0007016374136418301
NCT01069328,"Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC)",0.0006961833301044383,0.0008117338281848846
NCT01058902,The Effect Of Aspirin On Survival in Lung Cancer,0.0009021799653660135,0.0003747811003337755
NCT01058811,Established Lung Cancer Cell Line and Stroma Cell From Surgical Tissue,0.0006131233517919361,0.0005464261749308061
NCT01090830,Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung Cancer,0.0006168076657323911,0.0006391641731825073
NCT01018147,4D Image-guided Adaptive Radiotherapy for Lung Cancer: Patient Image Acquisition,0.0007678810664989533,0.0007272737493851486
NCT01046383,"Effect of IMN1207 Versus Casein on Weight Loss, Survival and Quality of Life in Non-small Cell Lung Cancer Patients",0.0007416474628900613,0.0007640042393314356
NCT01086254,SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer,0.0007617560147834784,0.0007294729723401426
NCT01003522,Evaluation of Stents to Open Restricted Airways in Patients With Centrally Placed Non-small Cell Lung Cancer,0.0007007436741842887,0.0005203565914890796
NCT01003964,Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV,0.0006201883751579362,0.0006996048066824915
NCT01057212,Trial of Bevacizumab and Ixabepilone for Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC),0.0006690395536500752,0.0006090290815432101
NCT01054482,Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in Locally Advanced Non-small Cell Lung Cancer,0.0007332689917126325,0.0006510119052876087
NCT01040780,Safety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) Patients,0.0009238006976049698,0.0011424821759722383
NCT01068210,Lung Cancer Exercise Training Study,0.0006277323202992166,0.0004736596749741842
NCT01014130,Hypofractionated Radiotherapy (Stereotactic) Versus Conventional Radiotherapy for Inoperable Early Stage I Non-small Cell Lung Cancer (NSCLC),0.0006312017779452039,0.0007940976584540258
NCT01014286,Lung Cancer Mutation Consortium Protocol,0.0009021799653660135,0.0005638612913824629
NCT01014598,Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung Metastasis,0.0007458122425774514,0.0008553765022498
NCT01006226,"64CuATSM and Hypoxia in Stage IV Non-small Cell Lung Cancer With Carboplatin, Paclitaxel, and Bevacizumab",0.0006042410005643293,0.000670198312768432
NCT01091376,Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC),0.0008116278769127356,0.0008960776920475647
NCT01064050,Role of a Silicone Prosthesis to Prevent Airway Obstruction Recurrence in Lung Cancers,0.00043630577745530104,0.0006261091328575242
NCT01041833,Effect of All-trans Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer and Expression of RAR-alfa and RAR-beta as Response Biomarker,0.0008208515989501525,0.0009684940222094161
NCT01051362,Pegylated Liposomal Doxorubicin and Carboplatin as First Line Treatment for Patients With Advanced Non-small Cell Lung Cancer,0.0007756783790514816,0.0008051687545416514
NCT01065415,Whole-Body Magnetic Resonance Imaging/Positron Emission Tomography (MRI/PET) in the Staging of Non-Small-Cell Lung Cancer (NSCLC),0.0006251612336686682,0.0007868256442534107
NCT01026844,Hydroxychloroquine With or Without Erlotinib in Advanced Non-small Cell Lung Cancer (NSCLC),0.0006894877823719198,0.0008115721406941746
NCT01027598,"Randomized, Double-Blind Trial of Erlotinib/Pazopanib or Erlotinib/Placebo in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer",0.000755186945097436,0.0007904342599123809
NCT01067794,Chemotherapy in Treating Patients With Lung Cancer,0.0009537358487992667,0.0007765248922868242
NCT01085136,LUX-Lung 5: Afatinib Plus Weekly Paclitaxel Versus Investigator's Choice of Single Agent Chemotherapy Following Afatinib Monotherapy in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib,0.0007375722239207042,0.0007549393098405779
NCT01038271,Integrated Versus Standard Palliative Care in Patients With Advanced Non-small Cell Lung Cancer (NSCLC),0.000790323881955081,0.0008092940434643162
NCT01038752,Evaluation of Non-cytotoxic Suramin as a Chemosensitizer in Non-small Cell Lung Cancer,0.0005973406063683249,0.0007790142449203392
NCT01000428,The Role of Positron Emission Tomography (PET) During Erlotinib Treatment for Non-small Cell Lung Cancer,0.0006469077888956382,0.0007656513877403432
NCT01028729,A Study of Endostar Combined With Chemotherapy Followed by Endostar Maintenance Therapy to Treat Advanced Non-small Cell Lung Cancer (NSCLC),0.0007227333828448878,0.0007913792788354988
NCT01048970,Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)- Containing Supplement in Patients With Advanced Lung Cancer,0.0006023189090327562,0.0005923711789747123
NCT01048645,Effect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung Cancer,0.0007814937967699395,0.0008519042642705637
NCT01088620,Panitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With Non-small Cell Lung Cancer,0.0007554040677641972,0.0006991456215796713
NCT01022671,Study of Camtobell Inj (Belotecan) on Weekly Schedule in Non-small Cell Lung Cancer (NSCLC) Patients Previously Treated With Chemotherapy,0.0008053328238450193,0.0008446813013337223
NCT01025284,A Study for Patients With Small-Cell Lung Cancer,0.0010398847775535747,0.0013816617057486628
NCT01005797,"Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers",0.0005123294677715688,0.0005431739002976598
NCT01011595,"Minimally Invasive, Diagnosis and Staging of Lung Cancer",0.000654852870206226,0.0005359934986457251
NCT01060137,Fentanyl Matrix in Lung Cancer Pain,0.0005220507856586041,0.0005709070602938237
NCT01079520,Endobronchial Ultrasound- Transbronchial Needle Aspiration (EBUS-TBNA) Versus Mediastinoscopy for Mediastinal Lymph Node Staging of Non-small Cell Lung Cancer (NSCLC),0.0005789629095670603,0.0006796668115163424
NCT01015443,"Cancer Vaccine Study for Stage III, Unresectable, Non-small Cell Lung Cancer (NSCLC) in the Asian Population",0.0006706761973968617,0.0007417791704066457
NCT01004601,Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer,0.0006680635670823879,0.0007735620316918707
NCT02445183,COPDGene/Lung Cancer Center Database,0.0006404461267699046,0.00048735395124575046
NCT02445872,Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy,0.0006208009765988473,0.0005520115770404817
NCT02459002,"Prospective Study to Determine Impact of Early Palliative Care Consult on Quality of Life (QOL), Cancer Related Symptoms In Advanced Lung Cancer Patients: Thoracic Pilot Project",0.0006766869950083432,0.0006449075028143389
NCT02416570,Is Clarithromycin a Potential Treatment for Cachexia in People With Lung Cancer?,0.0005676245951413456,0.0008021377457726447
NCT02416739,Anticancer Activity of Nicotinamide on Lung Cancer,0.0006432330555916884,0.0005849269037872067
NCT02496663,EGFR Inhibitor AZD9291 and Necitumumab in Treating Patients With EGFR-Positive Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase Inhibitor,0.0007207658034703462,0.0008071396180880242
NCT02404675,High Dose Icotinib in Advanced Non-small Cell Lung Cancer With EGFR 21 Exon Mutation,0.0008204168460454712,0.0009362005340646938
NCT02481830,Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung Cancer,0.0006627884662922232,0.00092858651223553
NCT02481726,68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CT,0.0005331813541810225,0.00039295266059918664
NCT02425748,Safety and Efficiency of γδ T Cell Against Non Small Lung Cancer ( Without EGFR Mutation),0.001319625915519793,0.0009719289765110788
NCT02400814,MPDL3280A and Stereotactic Ablative Radiotherapy in Patients With Non-small Cell Lung Cancer,0.0008424234620999345,0.0006976583046165385
NCT02410369,Study of S-588410 After Adjuvant Chemotherapy for Completely Resected Non-small- Cell Lung Cancer,0.0006374750434919015,0.000731431029379423
NCT02410603,Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer,0.0005262599515971002,0.0007275872062581409
NCT02410382,Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer,0.0006070708336374086,0.0007179644590402551
NCT02488928,E- Predict: EBUS ELASTOGRAPHY STRAIN in Lung Cancer,0.0006404625779993201,0.0004548427178519618
NCT02488694,Maintaining ERBB Blockade in EGFR-mutated Lung Cancer,0.0009021799653660135,0.0006444975784155138
NCT02417662,Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer,0.0007763249353088383,0.0007429186938114227
NCT02437760,The Prognostic and Predictive Value of the CA-125 Marker in Lung Cancer Monitoring,0.00047853505717619096,0.0005292620453353638
NCT02423590,Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung Cancers,0.0007136480341322888,0.0007931132872350826
NCT02423148,Pilot Study of Novel Fluorescence Endoscopic Device for Sentinel Lymph Node Mapping in Lung Cancer,0.0005476164751636118,0.00048103985479544975
NCT02407366,Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer,0.0007757972801333432,0.0006622755372536138
NCT02407912,Cisplatin for Malignant Pleural Effusion in Patients With Non-small-cell Lung Cancer,0.0007420472884523817,0.0005649963151254224
NCT02452463,Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation Therapy,0.0007379755505133314,0.0007620447825537241
NCT02470468,Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer,0.0006712971767359151,0.0007714866066614808
NCT02412384,The Detection of Circulating Tumor Cells (CTCs) in Patients With Lung Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment,0.0006270437735665171,0.0004818779272753814
NCT02414672,CareSTEPS: A Supportive Care Program for the Caregivers of Advanced Lung Cancer Patients,0.0007038240737952181,0.0004515178084856452
NCT02414139,Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer,0.0008363299289091292,0.0008432628265190162
NCT02462356,Multiple-portal VATS Versus Uniportal VATS Lobectomy for Non-small Cell Lung Cancer,0.0006406001480517856,0.0009304556746783434
NCT02499614,Crizotinib in Pretreated Metastatic Non-small-cell Lung Cancer With MET Amplification or ROS1 Translocation (METROS),0.000681442393246148,0.0005435874714639033
NCT02480634,Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer,0.000671235148550013,0.0006596910853201014
NCT02486718,Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010],0.0006874171230558369,0.0007777259357562251
NCT02484872,Has Inflammation a Significant Implication in Lung Cancer Evolution?,0.000640477600031944,0.0004981318202422781
NCT02495233,A Study of ASP2215 in Combination With Erlotinib in Subjects With Epidermal Growth Factor Receptor (EGFR) Activating Mutation-Positive (EGFRm+) Advanced Non-Small-Cell Lung Cancer (NSCLC) Who Have Acquired Resistance to an EGFR Tyrosine Kinase Inhibitor (TKI),0.0007252124049971263,0.0007090663718661613
NCT02493114,Functional Status in Patients Undergoing Curative Treatment for Lung Cancer,0.0007717112281393383,0.0006690432370989529
NCT02450539,A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer,0.0007334372801626722,0.0008351875294083193
NCT02448303,Pembrolizumab Alone and In Combination With Acalabrutinib (ACP-196) in Subjects With Advanced Non-small Cell Lung Cancer,0.0006409821703135626,0.0007178814796893161
NCT02448758,Cohort of Non-small Cell Lung Cancer With Mutation of the Nord Pas de Calais (CB(NPC)²),0.001319625915519793,0.00037898154412211913
NCT02448992,Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung Cancer,0.0006423927022429888,0.0008555349768167353
NCT02448225,18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules,0.0005849147368831561,0.0004399107242794772
NCT02448797,Icotinib Versus Vinorelbine/Platinum as Adjuvant Therapy in Stage II-IIIA Non-small Cell Lung Cancer With EGFR-mutation,0.0005935042787567704,0.0007697479120447539
NCT02403193,Trial of PBF-509 and PDR001 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC),0.0009069950996544442,0.0007265210438338651
NCT02438722,"S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer",0.0007140413403114369,0.0007717171277361503
NCT02490696,Comparative Study of the Hypoxia Measured in FAZA and F-miso PET/CT Scan in Patients With Non-small Cell Lung Cancer,0.0007153918895529155,0.0008145576891210353
NCT02453282,Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC).,0.0006490308788602787,0.0006712331752377083
NCT02421718,Standard Follow-up Program (SFP) for Lung Cancer Patients Treated With Radiotherapy or Chemoradiation,0.0006232116563413596,0.0005814168809010988
NCT02426658,Pemetrexed Disodium in Treating Patients With Stage IV Non-small Cell Lung Cancer and ECOG Performance Status 3,0.0007483884096586011,0.0008088883282489119
NCT02408016,Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma,0.0007516560100994357,0.0008338066840390783
NCT02451865,"Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung Cancer",0.0007588225842031533,0.0008470449980138678
NCT02497586,Feasibility of Magnetic Resonance Spectroscopy in Lung Cancer,0.0009021799653660135,0.00039391199082100667
NCT02443337,A Study of LY3023414 and Necitumumab in Squamous Lung Cancer,0.0007755999599544324,0.0008484053995472165
NCT02420314,Pharmacological Ascorbate for Lung Cancer,0.0009021799653660135,0.0006200342542782585
NCT02409108,Perfusion-Induced Hyperthermia in Lung Cancer,0.0006416391161799129,0.0005215502469523412
NCT02468024,JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer,0.0005683631729582512,0.0005088950635998502
NCT02468661,"A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET Amplification",0.0008705939530283448,0.0008118498728647675
NCT00101920,ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC),0.0006759138134756755,0.0006157965580279609
NCT00187980,Sleep Disturbance in Lung Cancer Patients.,0.0009086593654929983,0.0005861239736040184
NCT00190710,A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer,0.0007608255628354699,0.000750820512716524
NCT00184964,Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis,0.0007154387315621886,0.0007296787838170599
NCT00179686,A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer,0.0006467765101967188,0.0006805026704642827
NCT00185913,Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers,0.0005883429858081025,0.0007476780005431777
NCT00119613,A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa,0.0006664564768248517,0.0007364350758349334
NCT00119470,EUS-FNA in the Pre-Operative Evaluation of Patients With Lung Cancer,0.0007408503257062421,0.0005444803048753108
NCT00124280,Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC),0.000857519623148551,0.0008214828414907302
NCT00173524,PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC),0.0006538772949529393,0.0007963598790781508
NCT00173680,Methylation Status of CD44 Promoter Region in Primary Lung Cancer,0.0009039192634709594,0.0007242179250373989
NCT00125359,Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung Cancer,0.0006935177428983916,0.0007058801152711925
NCT00125372,Study of Tarceva and Targretin in Stage I-II Lung Cancer,0.0005844165765597508,0.0006447429452765193
NCT00171834,"Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung Cancer",0.0008916431212815958,0.00099557423926724
NCT00160069,Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung Cancer,0.0006597402310402139,0.000917805279646426
NCT00111839,Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer,0.0005548435179952922,0.0007033968994820437
NCT00193921,Chemoradiotherapy in Patients With Localised Lung Cancer,0.000911380809233255,0.00066487902727329
NCT00103116,"Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer",0.0007434987918150583,0.0006788831107472185
NCT00103363,Sputum Cytology in Screening Heavy Smokers For Lung Cancer,0.0005276179971572858,0.0005423069933711911
NCT00155116,SERPIN D1 and Its Role in Lung Cancer Invasion and Metastasis,0.0004664541666282898,0.000404206302307511
NCT00136890,PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers,0.0006719342086010902,0.0006581490566852481
NCT00136864,Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial),0.0006109068706804668,0.0005583704993773349
NCT00148395,Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.,0.0006804295726921455,0.0007242775997989893
NCT00191191,To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therapy in Patients With Non-small Cell Lung Cancer (NSCLC),0.0007741815105742675,0.0010421043674650591
NCT00191308,Molecular Profiling in Lung Cancer Patients,0.0009114380893250621,0.0008118026436552747
NCT00147537,"Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer",0.0006160485056179516,0.0006999887576562611
NCT00144053,A Phase Ⅲ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage Ⅲ Non-Small-Cell Lung Cancer,0.0007008218915637738,0.000601696341149417
NCT00153842,A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer,0.0007078100615376322,0.000684507841116317
NCT00150657,Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer,0.0006239589735740472,0.0005821934290829539
NCT00188890,Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers,0.0005245199862829752,0.00037165517357912073
NCT00188214,CT Perfusion Scans for Assessment of Lung Cancer Before and After Chemo +/- Radiotherapy,0.0004690910472861741,0.0006691810499076107
NCT00172042,A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC),0.000807799824423114,0.0007191909011356113
NCT00115206,Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy,0.0006993328319203598,0.0007405205876820158
NCT00100256,Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy,0.0006338648548391543,0.0006489149137853151
NCT00152477,A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer,0.0007505765270556049,0.0008686808780211618
NCT00132379,ABR-217620 in Combination With Docetaxel in Patients With Advanced Non-small Cell Lung Cancer,0.000828164255349925,0.0008314581879650364
NCT00132522,"EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide",0.0006900278828312615,0.0006273650166510114
NCT00107250,"AZD2171 and Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)",0.0006546295571348215,0.0007201289942499984
NCT00181545,Safety Study of Individualised Radiation Dose Determination for Lung Cancer Patients.,0.0007514654546042543,0.0006377931869669187
NCT00108186,Celecoxib Treatment for Lung Cancer,0.0007011707250284409,0.000411582898669917
NCT00175578,Detection of Early Lung Cancer by Serum Protein Expression Profiling,0.0005302505647331205,0.0005323195374292946
NCT00145418,Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer,0.000691811973361513,0.0006755378298480795
NCT00126581,Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer,0.000740788450179722,0.0008536676847094188
NCT00129844,Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer,0.0007224544488112093,0.0007245060036917818
NCT00180154,Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET,0.0006361817619976535,0.0009479679180319223
NCT00178256,Pulsed Paclitaxel And Daily Thoracic Radiotherapy For Inoperable (Stage I/II) Or Unresectable Lung Cancer,0.0004896937405060153,0.0007161206761884197
NCT02178163,Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer,0.0008226723979640161,0.0008496499008544614
NCT02162537,Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain Metastases,0.0007790445395973578,0.0008005206456628598
NCT02172027,Immunomagnetic Detection of Cancer Cells in Pleural Effusion in Lung Cancer Patients as Additional Staging and Prognostic Tool,0.0005767889961145028,0.000610220060592305
NCT02195336,dMR During First Line Treatment of Non Squamous Lung Cancer: Time Course and Prognostic and Predictive Impact.,0.0006463851111480886,0.0006383930334890372
NCT02134015,Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung),0.0007371556935757306,0.0007118692911246774
NCT02157883,"Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva)",0.000754626138648739,0.0006569789647706174
NCT02166658,A Study of Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet),0.0006681160970959033,0.0006332453465579763
NCT02166242,Ethaselen for the Treatment of Thioredoxin Reductase High Expression Advanced Non-small Cell Lung Cancers,0.0006421400504641923,0.0006261011607382298
NCT02183870,EUCROSS: European Trial on Crizotinib in ROS1 Translocated Lung Cancer,0.0009080341023612404,0.000688078946271535
NCT02111681,Calypso-based Deep Inspiration Breath Hold (DIBH) Radiation Treatments of Lung Cancer,0.0004654727490017112,0.0006294649672840428
NCT02147990,"TIGER-2: A Phase 2, Open-label, Multicenter, Safety and Efficacy Study of Oral CO-1686 as 2nd Line EGFR-directed TKI in Patients With Mutant EGFR Non-small Cell Lung Cancer (NSCLC)",0.0007869159309720462,0.0008442412806589117
NCT02193282,Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial),0.0007606113220219188,0.0008533076830805441
NCT02135679,The Detection Of Circulating Tumor Cells (CTC) In Patients With Non-small Cell Lung Cancer (NSCLC) Undergoing Definitive Radiotherapy Or Chemoradiotherapy,0.0007509963004619337,0.0006350507003812797
NCT02152631,A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer,0.0007752127122165661,0.001105776768433267
NCT02192697,An Open Study of ASP8273 in Patients With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations,0.0008450643502233471,0.0009307879057060059
NCT02133677,A Phase II Multi-center Pilot Study of Concurrent Temozolomide and Whole Brain Irradiation in Lung Cancer and Breast Cancer Patients With Brain Metastases,0.0006524644070331306,0.0005946582368067289
NCT02133508,A Study Examining Long Response in Lung Cancer Patients Treated With Tarceva (Erlotinib),0.0006541572967930753,0.0006206375275904283
NCT02117440,Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer,0.0005144585667259566,0.0005666592324680364
NCT02117908,Study of the Application of CPAP to Reduce Complications and Improve Lung Cancer Ablation Radiofrequency Treatment,0.0005247700139956107,0.0004960345736556648
NCT02179671,"Immune-Modulated Study of Selected Small Molecules (Gefitinib, AZD9291, or Selumetinib + Docetaxel) or a 1st Immune-Mediated Therapy (IMT; Tremelimumab) With a Sequential Switch to a 2nd IMT (MEDI4736) in Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer",0.0008609091097432457,0.0007163867625103822
NCT02109016,"A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations",0.0006870310093394129,0.0006476012748844112
NCT02109549,Influence of the Use of the Diabetic Drug Metformin on the Overall Survival and Treatment-related Toxicity in Advanced Stage Non-small Cell Lung Cancer Patients.,0.0007910895824052775,0.0008139232945854744
NCT02191059,Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Cancer,0.0005241486757048929,0.0006531719252109384
NCT02191891,BI 836845 Plus Afatinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC),0.0007720049878021905,0.0008135108340611189
NCT02113813,A Dose Escalation Study of ASP8273 in Subjects With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations,0.0007566715347941782,0.0007161262030768621
NCT02113852,"Study of Blood, Tumor and Adjacent Normal Tissue Samples From Chinese Smoking Induced Lung Cancer Patients",0.0006395867605574899,0.0006356730224497486
NCT02121379,Randomized Clinical Trial of 8 Weeks Pulmonary Rehabilitation in Advanced Stage Lung Cancer Patients With COPD During Cytotoxic Chemotherapy,0.0006455831696297532,0.0005467757189089536
NCT02121925,Registry Measuring the Impact of Adding RNA Expression Testing on Referral Decisions in Early Stage Lung Cancer Patients and Assessing the Disease-free Survival With Long-term Follow-up,0.0005757018163785253,0.0005074757087838624
NCT02121899,Registry Measuring Impact of RNA Expression Testing on Treatment Decisions in Early Stage Lung Cancer and Assessing the Disease-free Survival With Long-term Follow-up (ONC006),0.0004711320984750948,0.000479967793466299
NCT02121652,Cognitive Behavioral Therapy (CBT)-Insomnia for Lung Cancer,0.0009021799653660135,0.0010018539106278928
NCT02199886,Dose-escalation Study of BIBH 1 in Patients With Non-small Cell Lung Cancer Scheduled for Surgical Resection,0.0007957421263431613,0.0007119480542796036
NCT02196844,Yoga Program for Lung Cancer Patients and Caregivers,0.0007292946277282864,0.0005903631459563028
NCT02149576,Does Intense Regimented Surveillance Improve the Rates of Therapeutic Re-Intervention After Lung Cancer Surgery,0.0004907656295985725,0.000634460837725531
NCT02189967,Postoperative Radiotherapy of Non-small Cell Lung Cancer: Accelerated vs. Conventional Fractionation,0.0006702913506167608,0.0007458875826410788
NCT02186847,Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer,0.0007653368782313537,0.0008741789335737143
NCT02185495,"Screening for Early Lung Cancer in Shanghai, China",0.000903370699001885,0.00034208735313773534
NCT02151721,Phase I of Vorinostat-Iressa Combined Therapy on Resistance by BIM Polymorphysim in EGFR Mutant Lung Cancer,0.0005055582490644242,0.000498073022576243
NCT02161523,The Impact of Lung Cancer-derived Fibroblasts on Mast Cells Activation,0.0006400525668906703,0.00041832946186990414
NCT02161991,Aprepitant for Chemotherapy Induced Nausea and Vomiting in Chinese Advanced Non-small Cell Lung Cancers,0.000671773285284074,0.0004747937970993024
NCT02145078,Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer,0.0007348001350181111,0.0008245804831769266
NCT02132884,Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer,0.0007345391102218376,0.0007987045017001018
NCT02132325,Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer,0.000650109271049052,0.0007738311747232708
NCT02182050,Efficacy and Safety of Oral Treatment With BIBF 1120 ES in Advanced Non-small-cell Lung Cancer,0.000810813364560448,0.0007436147402485646
NCT02182232,A Dose Escalation Study of BIBF 1120 Together With Paclitaxel and Carboplatin in Patients With Advanced Stage Non-small-cell Lung Cancer,0.0007395495575678951,0.0008464528816794524
NCT01102517,A Trial on Video-assisted Thoracoscopic Surgery and Axillary Thoracotomy for Resection of Early-stage Non-small Cell Lung Cancer,0.0005798639288937391,0.0006440956079649736
NCT01102231,Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC),0.0006812185113415327,0.0007718899688659831
NCT01188707,A Trial of Belinostat in Combination With Erlotinib in Patients With Non-small Cell Lung Cancer,0.0007723263392212541,0.0008919688762569727
NCT01188486,Pulmonary Interstitial Lymphography in Early Stage Lung Cancer,0.0004942334699913137,0.0007138938841713632
NCT01140958,A Retrospective Pharmacoeconomic Study of Lung Cancer,0.0011026363996239049,0.0004699283059907408
NCT01171924,"A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors",0.0006787054138500363,0.0006265168072063075
NCT01161173,An Observational Study of Tarceva (Erlotinib) in Routine Daily Clinical Practice as Second Line Treatment in Patients With Non-small Cell Lung Cancer,0.0007691950337214495,0.0007578730000452354
NCT01179685,Diagnostic Utility of Pleural Fluid MAGE Assay in Patients With Pleural Effusion From Primary Lung Cancer,0.0005946358590135829,0.0005633468136064869
NCT01179308,Regional Anesthesia and Lung Cancer Recurrence,0.0006412730215742715,0.00042870944177951216
NCT01159964,"Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by Surgery",0.0007275144531883993,0.0008483017926480973
NCT01189435,Erlotinib Re-Challenge for Recurrent EGFR-mutant Lung Cancer in Patients Who Previously Received Adjuvant Erlotinib or Gefitinib,0.0006048673658179431,0.0006642719687875484
NCT01153984,A Study of Tarceva (Erlotinib) in Patients With Advanced and/or Metastatic Non-small Cell Lung Cancer With EGFR Positive Mutation (BIOTEC),0.0008384312243691338,0.0007545106011597985
NCT01153399,A Non-interventional Study (NIS) Registry for the Epidemiological and Scientific Evaluation of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) (Stage IIIB/IV Non-small Cell Lung Cancer).,0.000890394509427075,0.0008170128792192948
NCT01194453,Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin for Advanced NSCLC Metastatic Non-small Cell Lung Cancer,0.0006691356188852062,0.000598782182619219
NCT01158170,Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001),0.0006333631022995086,0.0006156265361908199
NCT01172314,Effects of Essential Amino Acid Intake on Net Protein Synthesis in Weight-losing Non-small Cell Lung Cancer Patients,0.000738573502679732,0.0006140106809081899
NCT01196234,Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung Cancer,0.0006787543502903259,0.0007388903869495362
NCT01141946,Pleural Ultrasonography in Lung Cancer,0.0009051430913741889,0.0006588713789875926
NCT01138163,Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer,0.0008400944096625396,0.00080986888472304
NCT01138358,Study of Episodic Breathlessness in Patients With Lung Cancer or Other Advanced Disease,0.0006930488692787049,0.0006325612092343699
NCT01138748,Prediction of the Effectiveness of Hypofractionated Radiation Therapy in Early Stage Lung Cancer by Bio-imaging and Biomarkers,0.00047363880679017055,0.0005898006346273279
NCT01138722,Predicting Cell Death by Radiation Therapy in Early Stage Non-small Cell Lung Cancer: a Prospective Translational Trial,0.0006450414768804729,0.0006584003780837662
NCT01130766,Asymptomatic Brain Metastasis in Non-small Cell Lung Cancer (NSCLC),0.0006748820328918722,0.0006490055045456288
NCT01130714,Resistance Training in Lung Cancer Patients on Chemotherapy,0.0007596732943278026,0.0006870826538411794
NCT01160601,Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer,0.000663584321986389,0.0008414298603377948
NCT01133067,Telephonic Contact and Subsequent Physical Follow up Treated Lung Cancer Patients,0.0007301948064939997,0.0006699779704890495
NCT01109524,Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer,0.0007023024643428428,0.0008411045758094033
NCT01192256,Studies Examining the Importance of Smoking After Being Diagnosed With Lung Cancer,0.00047319699314699113,0.0003390330430870672
NCT01192230,Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients,0.0008531551755298863,0.0009377575627575489
NCT01192919,Tumour Registry Lung Cancer (TLK),0.0006610956277669879,0.0007038294076160744
NCT01121393,BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC),0.0006087072546182618,0.0006512864433899925
NCT01134861,Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung Cancer,0.000868423958954544,0.0007676731167930744
NCT01137968,Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC),0.0006161973032617851,0.0007381657744147531
NCT01165216,Japanese Study of Ipilimumab Administered in Combination With Paclitaxel/Carboplatin in Patients With Nonsmall-cell Lung Cancer,0.0006758603478472647,0.0008764358743299019
NCT01124864,A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy.,0.0007472302644790626,0.000695764054345547
NCT01117714,Surgical Versus Non-surgical Staging of Lung Cancer,0.0006717785110183444,0.0006286650040925096
NCT01125995,Early Versus Late Concurrent Chemoradiation for Limited Stage Small-cell Lung Cancer,0.0005608646712805165,0.0007129678999853504
NCT01178190,The Role of Narrow Band Imaging Videobronchoscopy in Lung Cancer,0.000643303643884101,0.0005352826009052269
NCT01112631,Prospective Study of Quality of Life in Non-small Cell Lung Cancer (NSCLC) Patients Treated With/Without Postoperative Radiotherapy,0.00083270229826821,0.000648349822493475
NCT01170923,FDG-PET Scan Response Guided Chemotherapy Strategy for Advanced Non-small Cell Lung Cancer,0.0006428922994365444,0.00048445893466118753
NCT01199068,CS-7017 in Combination With Erlotinib in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC),0.0006757978680854757,0.0007757146852784821
NCT01199055,CS-7017 in Combination With Carboplatin/Paclitaxel in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC),0.0006617987514296649,0.0007311741240543707
NCT01147562,Biomarker Discovery and Validation in Lung Cancer,0.0009260935920344401,0.0006347164126974507
NCT01182155,Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation,0.0006275783572746824,0.0006267180965800047
NCT01185314,To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC),0.0008326101500030699,0.0008557980174650401
NCT01185639,Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer,0.0007635870122773847,0.0006823193166913746
NCT01176383,Impact of a Gene Test for Susceptibility to Lung Cancer in Smokers,0.0005301087778424596,0.00037028288048187685
NCT01176487,Palliative 3-Dimensional Conformal Radiation Therapy in Reducing Radiation Side Effects in Patients With Lung Cancer. ICORG 06-34,0.0006665964215928055,0.0005799132377369889
NCT01193881,RO4929097 and Erlotinib Hydrochloride in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer,0.0008197229684906362,0.0007954089335851464
NCT01193959,Pemetrexed in Advanced Non-small Cell Lung Cancer,0.0008283931302753013,0.0006130617349717266
NCT01136083,Effect of Exercise Training on Angiogenesis and Cachexia in Lung Cancer Patients,0.0005886898464153849,0.0005046475901853962
NCT01167530,Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer,0.0007221439076924822,0.0006528188753389697
NCT01114958,Pilot Study of Intra-Arterial Cisplatin With IV Thiosulfate in Patients With Lung Cancer or Lung Metastases,0.0006431734652596045,0.0006192596451921846
NCT01101334,Study of Erlotinib With or Without Investigational Drug (CS-7017) in Subjects With Advanced Non-small Cell Lung Cancer,0.0007381559273059921,0.0008192028099907423
NCT02043665,Systemic Treatment Of Resistant Metastatic Disease Employing CVA21 and Pembrolizumab in Non-small Cell Lung Cancer and Bladder Cancer (STORM/ KEYNOTE-200),0.0005861798911790563,0.0006801489661447235
NCT02016209,Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Lung Cancer,0.0005594089501101584,0.0005270487077385008
NCT02016872,"Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) Patients",0.0007307921027069629,0.0007339628849838812
NCT02039674,A Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants With Lung Cancer (MK-3475-021/KEYNOTE-021),0.0005597118411921387,0.0007131626692567672
NCT02000531,Progression Free Survival (PFS) Using Erlotinib for Non-Small-Cell Lung Cancer (NSCLC) in Chinese Population,0.0006867660245609902,0.0007609511748122845
NCT02000947,A Phase 1b Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Non-small Cell Lung Cancer,0.0007420607923693936,0.0009485414441608973
NCT02000518,Emergency Radiotherapy in Metastatic Spinal Cord Compression of Patients With Non-small Cell Lung Cancer,0.0007518365406072782,0.0006632703464071353
NCT02070497,Effectiveness of Nursing Case Management for Lung Cancer Patients,0.000633645023579934,0.000896757032081632
NCT02034097,A Study to Evaluate Foretinib in Subjects With Non-Small-Cell Lung Cancer,0.0007331923089704953,0.0006066096531397783
NCT02054052,Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer,0.00047032265844867884,0.0004094093722990853
NCT02009436,Inhaled Azacitidine in Patients With Advanced Non-small Cell Lung Cancer,0.0007996035905501744,0.000865627233159032
NCT02009319,Endobronchial Ultrasound Elastography: the Utility of Strain Ratio for Lymph Node Staging in Lung Cancer Patients,0.0005645741476141284,0.0005856790525054504
NCT02093962,Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer,0.0008036019802437144,0.0009900710278831712
NCT02001168,Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in PhaseⅠB,0.0006387188774675704,0.0005853409673628354
NCT02066870,Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI,0.0007287726539013805,0.0006694261506771825
NCT02062515,Icotinib in Advanced Non-small Cell Lung Cancer (NSCLC) With Hepatic Insufficiency,0.0007366286606493378,0.0010865572272745212
NCT02024113,LC-NMR Study Biomarkers to Detect Lung Cancer,0.0007901567385696959,0.0005513763513536895
NCT02094950,Acupuncture Feasibility Trial for Dyspnea in Lung Cancer,0.0006436099072067628,0.0003696578834296796
NCT02087176,A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer,0.0005637583519664335,0.000793063205769466
NCT02087241,Ph II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung Cancer,0.0005606735668385771,0.000878586371856535
NCT02031601,Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung Cancer,0.0007598281918687527,0.0007013832278808385
NCT02098954,Erlotinib Combined With Chemotherapy in TKI Resistant Non-Small Cell Lung Cancers,0.0006812066098836911,0.0006749428176538598
NCT02049151,Tecemotide Following Concurrent Chemo-radiotherapy for Non-small Cell Lung Cancer,0.0009200238696627492,0.0006321120996410622
NCT02083679,Sym004 in Subjects With Stage IV Non-small Cell Lung Cancer,0.0009378123386472689,0.0005364783399986361
NCT02018523,Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer,0.0006699156195779921,0.0008417584783716674
NCT02079636,A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC),0.0005383950226805029,0.0006817756578589388
NCT02004184,Pemetrexed in Advanced Non-Small-Cell Lung Cancer: at Progression vs Maintenance Therapy After Induction Chemotherapy,0.0006298836810939771,0.0008356741164778116
NCT02075957,"Identification by Microarrays of the Risks of Metastatic Relapse, Toxicity and Resistance to Adjuvant Chemotherapy in Completely Resected Non-small Cell Lung Cancer",0.000572969578050461,0.0005306677570641455
NCT02027428,Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer,0.000691544784546281,0.0008947830220448543
NCT02027090,High Dose Versus Routine Dose Icotinib in Advanced Non-small Cell Lung Cancer Patients With Stable Disease,0.0007638503921936613,0.0007688925575887921
NCT02029209,To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer,0.0008153136879071067,0.0008112964939953215
NCT02014324,Single Scope Staging of Lung Cancer With Endosonography,0.0006428030323396813,0.0006837388060830092
NCT02073968,PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer,0.0007347345734416951,0.000899853087469515
NCT02050100,Biomarkers for Diagnosis of Lung Cancer,0.0006697488480851354,0.000612942147437258
NCT02007070,Study of Pembrolizumab (MK-3475) in Participants With Advanced Non-small Cell Lung Cancer (MK-3475-025/KEYNOTE-025),0.0007934978953666193,0.0009095916064410688
NCT02007538,Thin Prep Versus Traditional Cytological Procedure for Lung Cancer,0.0009021799653660135,0.00043902196303767266
NCT02095808,Feasibility Study Using Imaging Biomarkers in Lung Cancer,0.0005417446507278581,0.0005238854874024363
NCT02095782,Chemotherapy and Erlotinib for Lung Cancer With Low Abundance Epidermal Growth Factor Receptor Mutation,0.0005121587305592703,0.0005094266468373606
NCT02067858,An Outcome Analysis for Stereotactic Body Radiation Therapy (SBRT) Treatment of Non-Small Lung Cancer Patients Using 4D PET/CT With Real-Time Position Management (RPM™) System and a Concomitant Evaluation of the Impact and Performance Characteristics of the Immobilization System,0.0005976395011127169,0.000771039687758468
NCT02084823,Vaccine Therapy in Treating Lung Cancer Patients With Cancer Stem Cells,0.0005946150601891557,0.0005291105924793715
NCT02030444,Extensive Staging in Lung Cancer,0.0017222839564628085,0.0005282601324476965
NCT02069418,Theranostic Tool During Erlotinib Treatment in Non-small Cell Lung Cancer Patient,0.0008613257589914538,0.0009341388985252635
NCT02040870,LDK378 in Adult Chinese Patients With ALK-rearranged (ALK-positive) Advanced Non-small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib,0.000793869196517765,0.0007752697409471645
NCT02063828,Reducing Lung Cancer Survivors' Anxiety and Dyspnea (RELAX),0.0006424343850022681,0.0007274833519779517
NCT02059889,Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer,0.0005631543792148277,0.0006723122878286239
NCT02044601,Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT),0.00047359080623535785,0.0005675215573724779
NCT02002117,Genotyping of Non-small Cell Lung Cancer,0.0009200505918507477,0.0009536277711093925
NCT00965731,"Erlotinib Is Being Studied With Or Without An Investigational Drug, PF-02341066, In Patients With Lung Cancer",0.0007474716293159453,0.000890232797429469
NCT00983047,Nimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung Cancer,0.0007769090242381078,0.0006137197318943229
NCT00983307,A Study of Erlotinib Plus Radiotherapy (RT) for Patients With Advanced or Inoperable Non-Small-Cell Lung Cancer,0.0008739681994244027,0.0008947319741750812
NCT00955305,"Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer",0.0007459811989121979,0.0008432212294070903
NCT00950365,Pharmacodynamic Separation of Pemetrexed and Erlotinib as Second-line Therapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC),0.0008117690421483525,0.000782373647306593
NCT00910546,Image Guided and Breathing Adapted Radiotherapy of Early Stage Lung Cancer,0.0004939410938704635,0.000551168144745369
NCT00958555,A Study of Predictive and Prognostic Markers in Patients With Non-small Cell Lung Cancer,0.0008268533788445728,0.0010109902347169386
NCT00967083,Support Needs and Preferences of Family Caregivers of Lung Cancer Patients,0.0006346574316576516,0.0005240213582026842
NCT00920010,S9925: Collecting and Storing Samples From Patients With Lung Cancer,0.0013051624920591663,0.0007496253675354766
NCT00973427,DNA Chip Based Prognosis of Lung Cancer,0.0009027748755293482,0.0007769928749736577
NCT00973310,Erlotinib Concurrent With Radiation Therapy in Non-small-cell Lung Cancer,0.0007208836847068994,0.0009856267926563096
NCT00993499,Trial of Continuous Once Daily Oral Treatment Using BIBW 2992 (Afatinib) Plus Sirolimus (Rapamune®) in Patients With Non-small Cell Lung Cancer Harbouring an EGFR Mutation and/or Disease Progression Following Prior Erlotinib or Gefitinib,0.0007320383446449867,0.0006732012301918972
NCT00923884,Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer,0.0007011808854665647,0.0007294797974063748
NCT00923949,Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer,0.000756888966679502,0.0008985237848598413
NCT00995761,Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC),0.000730902822319786,0.0008567972497822296
NCT00906282,"Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer",0.0006950181338957182,0.0007162540721040625
NCT00979888,Study of How Caregivers Help Patients Cope With Respiratory and Other Symptoms Caused by Lung Cancer,0.0006637865424740852,0.0005071337992205182
NCT00940069,TS Gene Polymorphism Predicts Effect in Patients With Advanced Lung Cancer,0.0010194857367323673,0.0007217019752211941
NCT00997724,Assisted-VATS Sleeve Lobectomy for Non-small Cell Lung Cancer,0.0007348753079825787,0.0007079025948665927
NCT00900419,"Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers",0.0005632973343449548,0.0005487841403049235
NCT00900328,Study of Tumor Samples From Patients With Lung Cancer,0.00084300705135284,0.0007308494893949349
NCT00900835,"Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer",0.0005559340006078182,0.00040764805021438304
NCT00905801,Computed Tomography (CT) Perfusion Imaging of Lung Cancer,0.0006420100873352906,0.0006819147716785346
NCT00932152,Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer,0.0006183039779919951,0.0006950898493482323
NCT00994097,NGR-hTNF in Combination With Standard Chemotherapy to Treat Patients With Advanced Non-small Cell Lung Cancer,0.0007850453466154351,0.0008297557483386035
NCT00954278,Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung Cancer,0.0007903119384564896,0.0007721361046434033
NCT00985998,Nimotuzumab in Combination With Cisplatin and Docetaxel for Patients With Advanced Non-small Cell Lung Cancer,0.0007794903105421212,0.0007887104828219508
NCT00988858,A Study of Advanced or Metastatic Non-small Cell Lung Cancer,0.0008127973237002255,0.0008595709144831045
NCT00960115,Study of Tecemotide (L-BLP25) in Participants With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy,0.0006717426757026797,0.0009002164905526645
NCT00991796,CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC),0.0006328945490986233,0.0007387675111520771
NCT00913705,Neoadjuvant or Adjuvant Chemotherapy in Patients With Operable Non-small-cell Lung Cancer,0.0007299275240278691,0.0008148545239001287
NCT00970645,Study Comparing EBUS & EUS to Mediastinoscopy in Staging and Detection of Lung Cancer,0.0006302330241882233,0.0005054775784112856
NCT00956852,Study on Systemic and Airway Cytokines and Oxidative Stress in Lung Cancer Patients Undergoing Surgery,0.0006503058645549429,0.0006207598008292507
NCT00071188,ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC),0.0006822095471873378,0.0007288336274019348
NCT00071344,Analysis of Brain Metastasis in Patients With Lung Cancer,0.0009184615619803964,0.0007754762208027633
NCT00006017,Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer,0.0007996537132861188,0.0007887595673134543
NCT00006484,Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007453739134900945,0.0007559064485921103
NCT00006470,Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery,0.0007405235793623367,0.0008607497109163281
NCT00006212,Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer,0.000750231376585075,0.0008649369250012157
NCT00006229,Paclitaxel and Carboplatin With or Without BMS-275291 in Treating Patients With Advanced or Metastatic Non-small Cell Lung Cancer,0.0008048959095282954,0.0008062256090765744
NCT00006019,"Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer",0.0006829885115012267,0.0007720289924054963
NCT00006877,Temozolomide in Treating Patients With Metastatic Non-small Cell Lung Cancer,0.0008307036024095793,0.0009428074035262112
NCT00006929,"Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer",0.0007479952912200126,0.0009051621991146208
NCT00006087,Chest X-Ray or Chest CT Scan in Patients at High Risk of Developing Lung Cancer,0.0005645205657421805,0.00040938748273004375
NCT00006378,Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer,0.0007839150437604115,0.0007722390439889853
NCT00006004,Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer,0.0006452752134561637,0.0006718495416287384
NCT00084409,Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease,0.0006364489085166157,0.0006063495073377078
NCT00033527,INS316 Compared With Saline for Sputum Collection in Diagnosing Lung Cancer,0.0004724318953910434,0.0003854564469786966
NCT00016237,"Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment",0.000593844809961018,0.0006482181670363218
NCT00063219,Study Evaluating MAC-321 in Non-small Cell Lung Cancer Refractory to Platinum-based Therapy,0.0007618523751742779,0.0009093608733722908
NCT00063258,Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer,0.0006925913719327887,0.0007996555151226371
NCT00063388,Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer,0.0010398847775535747,0.001208663519200815
NCT00085839,Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2,0.000804529552466299,0.0008232683211713745
NCT00078260,A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung Cancer,0.0007390805781585993,0.0006791685650340152
NCT00012103,Computed Tomography for Early Detection of Cancer in Women Who Are at Risk for Lung Cancer,0.0006416238522736437,0.0004121419703644201
NCT00074295,S0310: Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Bronchoalveolar Lung Cancer,0.000677989405486854,0.0006073920778397071
NCT00014066,Photodynamic Therapy Plus Brachytherapy in Treating Patients With Lung Cancer,0.0007270423740900351,0.0006538288731655512
NCT00049790,Safety and Efficacy Study of rhAngiostatin Administered in Combination With Paclitaxel and Carboplatin to Patients With Non-Small-Cell Lung Cancer,0.0007989927502677943,0.0008326206227933443
NCT00049543,"Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery",0.0007392907207573208,0.0008749245650260109
NCT00047840,This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.,0.0008354783515340502,0.0010091543274472904
NCT00047736,A Study With Tarceva and Chemotherapy vs. Chemotherapy Alone in Patients With Advanced Lung Cancer,0.0007177426821043829,0.0008810367565046988
NCT00019006,"Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer",0.0006348631601801632,0.0006431755438938514
NCT00019201,Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer,0.000465869267428046,0.000548504887045395
NCT00003053,"Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed",0.0007572239580309722,0.0007710687713919954
NCT00003762,Docetaxel and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007543560453384678,0.0007700861234835607
NCT00003089,"Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer",0.0007938677225288254,0.0008435582050138887
NCT00003869,Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer,0.0007574427290940367,0.0007862256359551027
NCT00003881,Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0008235798633800733,0.0008344083375509114
NCT00003159,Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer,0.0008262211036424721,0.0007741127179672937
NCT00003090,Biological Therapy in Previously Treated Patients With Non-small Cell Lung Cancer,0.0009374843581813449,0.0009103969939325821
NCT00003313,Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer,0.0007505303918398213,0.0007784459522570068
NCT00003284,High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer,0.0006422898888472932,0.000767814984045061
NCT00003111,Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer,0.0007900527421584887,0.0009111976274070956
NCT00003072,Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer,0.0007648282667817274,0.0008678736154158764
NCT00003117,Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0008267440582262177,0.0008302404934722196
NCT00003202,Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer,0.0007797063600441538,0.0007654632553019885
NCT00003803,"Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed",0.0007838330082199161,0.0007657110855273672
NCT00003240,Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer,0.0007814271908652996,0.000802320046191294
NCT00003062,Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer,0.0009389402908939703,0.0008873109654012404
NCT00003974,"Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma",0.0007349473619011562,0.0008000201802011391
NCT00003002,"HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer",0.0007100270516405489,0.0007505413775289048
NCT00003589,Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0008815473270299854,0.0007748507254170824
NCT00003901,"Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery",0.0008044372719600572,0.0008344430174851324
NCT00003154,Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0009028578678224505,0.000948710921604773
NCT00003587,S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007819313860699715,0.0008927980947637562
NCT00003831,Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer,0.0007356118064802448,0.0007094007831110023
NCT00003692,Video-Assisted Surgery in Treating Patients With Non-small Cell Lung Cancer,0.0009374788495315966,0.000871810316268203
NCT00003231,Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer,0.0008331587101543619,0.0009195257270437104
NCT00003562,Docetaxel Plus Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007626400842158926,0.0009280965258698568
NCT00003006,Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer,0.0007734619947238958,0.0006748725521951633
NCT00003900,Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer,0.0007708963333359243,0.0009155928958040726
NCT00003317,Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Stage IIIA Non-small Cell Lung Cancer,0.0008023925903863009,0.0007753750913399811
NCT00003037,Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer,0.0007560772992662272,0.0008755266757101385
NCT00003599,Vitamin E in Preventing the Side Effects of Isotretinoin in Former and Current Smokers Who Are Receiving Isotretinoin to Prevent Lung Cancer,0.00043859157881816365,0.0005530329765088216
NCT00003685,Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer,0.0008420256408422165,0.0007310701170771613
NCT00003387,"Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery",0.0007622705123233877,0.0007772013006763584
NCT00003235,Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Can Not Be Surgically Removed,0.0007513195539148795,0.0007817287501302644
NCT00003989,"ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma",0.0007645863313478154,0.0008911071548658323
NCT00003666,Irofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer,0.0008087784575565356,0.0009261264700354311
NCT00003158,S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer,0.0007839150437604115,0.0008862274630650188
NCT00088933,Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer,0.0005926415714558145,0.0006716152310979396
NCT00008385,Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer,0.0007283110515407046,0.0007430533076822628
NCT00008255,INS316 in Diagnosing Lung Cancer in Patients With Untreated Lung Cancer,0.0007427998875,0.0006512410103994913
NCT00055978,Celecoxib in Preventing Lung Cancer in Former Heavy Smokers,0.0006472857061313897,0.0006416091788117833
NCT00040560,Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer,0.0005355685737627136,0.0005561577208200268
NCT00040768,Bortezomib in Treating Patients With Advanced Non-small Cell Lung Cancer,0.000874842688360485,0.0008902408388524074
NCT00034957,Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC),0.0008431620385110157,0.0010484649713640513
NCT00034697,Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143),0.0005934584905798167,0.000613995035332377
NCT00034346,ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC),0.000693942892912088,0.0006357942717844812
NCT00077883,TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC),0.0006657695036768802,0.0007943938609195471
NCT00043823,Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer,0.0006725121004572839,0.0006816713022974984
NCT00099879,Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer,0.0008966911784308734,0.0009992844353199962
NCT00048087,Iressa/Docetaxel in Non-Small-Cell Lung Cancer,0.0007500352391179312,0.0007493837726142902
NCT00059605,Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer,0.0008351855997263207,0.0008038372685265255
NCT00021008,ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer,0.0009129494729573775,0.0008739447206929423
NCT00021333,Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer,0.0006121185540808552,0.0007113562175864387
NCT00020202,FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer,0.0009386476390305018,0.0009700739969829631
NCT00020007,Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery,0.0005854301282625595,0.0005596481066453931
NCT00002519,Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer,0.0007586001114628469,0.0009196662047970058
NCT00002667,Early Detection of Second Lung Cancer in Patients With Stage I Non-small Cell Lung Cancer,0.0008407154219657187,0.000757201103676506
NCT00002484,Radiation Therapy Using 3-Dimensional Treatment Planning in Patients With Non-small Cell Lung Cancer,0.000803786848045818,0.0008318107792799185
NCT00002550,Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer,0.0007990854478822947,0.0007994783092192829
NCT00002623,Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer,0.0007819718670716724,0.000778733984760078
NCT00002583,Vinorelbine Plus Cisplatin or No Further Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Surgically Removed,0.0007515675559458511,0.0008041265819430875
NCT00002537,Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer,0.0008413475450363636,0.0009300504593084978
NCT00002823,Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer,0.0007963864374646166,0.000836903133123856
NCT00002911,Marimastat in Treating Patients With Stage III Non-small Cell Lung Cancer,0.0008172437446888706,0.0007267081447850678
NCT00002577,Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer,0.0009783620821514655,0.0008687893331384208
NCT00002969,S9714: Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007896985774549294,0.000948557480636
NCT00002972,Paclitaxel in Treating Patients With Lung Cancer,0.0009350622036678388,0.0008227082646903006
NCT00002624,Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function,0.0007381378902251691,0.0008196194517024265
NCT00002642,"SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer",0.0007819718670716724,0.0008881472299571744
NCT00002852,Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer,0.0008090615398533644,0.0008096613181945269
NCT00002887,Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer,0.0008129912163758785,0.0009531093832532741
NCT00002656,Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0008746084358902974,0.0009660021264933595
NCT00005868,Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer,0.0007545010250292911,0.0009371106064537921
NCT00005065,"Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer",0.0007990854478822947,0.0008931639348957627
NCT00005989,R115777 in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer,0.000829248034659412,0.0009420853139543176
NCT00005055,Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0007983672067218351,0.000819362705224352
NCT00005037,"Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer",0.0007772569105631002,0.0009364626767383262
NCT00005071,Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer,0.0006813184087229097,0.0006748500791738332
NCT00005872,Nitrocamptothecin in Treating Patients With Recurrent Non-small Cell Lung Cancer,0.0009371887942508499,0.0009691657359773386
NCT00005825,Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007819313860699715,0.0009409006386284196
NCT00005091,DX-8951f in Treating Previously Untreated Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007438949302197502,0.0009216368377211498
NCT00005838,Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery,0.0007443265825788143,0.000759404793293448
NCT00005093,Gemcitabine With or Without CI-994 in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0008806239942645724,0.0008056312134148878
NCT00005883,Phenethyl Isothiocyanate in Preventing Lung Cancer in People Who Smoke,0.0006408393380892374,0.0005172664491424902
NCT00005666,Utility of Anatometabolic Imaging for Radiation Treatment Planning for Lung Cancer,0.0005695332520383138,0.0007006102767639118
NCT00005849,"Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer",0.0007520315805055033,0.0009167511005392194
NCT00005630,Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer,0.0008086922587722424,0.000747435230605532
NCT00086268,Non-small Cell Lung Cancer Study US75 (Z-PACT),0.0010532469033602801,0.0008336475482739668
NCT00050973,"Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer",0.0007659098700008529,0.0008946540391078501
NCT00050960,"Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer",0.0007659098700008529,0.0008946540391078501
NCT00004264,"Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer",0.0007808920891798252,0.0008633010767291674
NCT00004930,Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases,0.0006341414558761912,0.0007985629102823483
NCT00004011,S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer,0.0008331587101543619,0.0007907231379247549
NCT00004138,Positron Emission Tomography for Detecting Non-small Cell Lung Cancer,0.0009350929614614421,0.0007582638124370467
NCT00004209,Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007819313860699715,0.0008071129277029751
NCT00004160,Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed,0.0007679947682120603,0.0008893628271242018
NCT00004126,Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung Cancer,0.0008125335275361117,0.0009357560365864477
NCT00004265,Paclitaxel in Treating Patients With Recurrent or Refractory Non-small Cell Lung Cancer,0.0009570871455117237,0.0009833396853041845
NCT00004096,Carboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007545163839584464,0.000920236449713162
NCT00004887,Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery,0.0007636316492824812,0.0007749038046615382
NCT00004253,Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery,0.0007463619312743445,0.0009151606539223828
NCT00004202,"Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer",0.000747686616432318,0.0008717981195685869
NCT00004199,Prinomastat and Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Non-small Cell Lung Cancer,0.000764434196799321,0.0007353031762512166
NCT00004159,Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid Tumor,0.0007617549969242241,0.0008698322687816317
NCT00004093,Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer,0.0007839150437604115,0.0008817816178479342
NCT00004238,10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007759198563676385,0.0009357809576600375
NCT00004100,Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0008009401837648471,0.000774631247062256
NCT00004924,Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0008138004807435189,0.0008510004652773673
NCT00004139,Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007391799441881038,0.0007845847805867296
NCT00004151,Acridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0008746084358902974,0.0009307005413286808
NCT00004979,Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors,0.0007687824868648579,0.0008842366840118446
NCT00004201,"Gemcitabine Plus Carboplatin or Cisplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer",0.0007499506971180742,0.0007832253679699815
NCT00004859,"Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer",0.0007500629652653388,0.0007634438798385513
NCT00004883,Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2,0.0007761109513755692,0.0007998614296501215
NCT00080509,Effectiveness of KOS-862 in the Treatment of Lung Cancer,0.0007023854012243928,0.000819791944238565
NCT00024076,Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer,0.0008092658011574729,0.0009066103471656723
NCT00035152,Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer,0.0006611906578816203,0.0007912636197491807
NCT00056004,Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia,0.0006337066724048772,0.0006696402576289482
NCT00061997,Inositol in Preventing Lung Cancer in Patients With Bronchial Epithelial Dysplasia Who Are Current or Former Smokers,0.0006375707244259437,0.0005264573831726885
NCT00090961,"S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung Cancer",0.0006070561486204315,0.0005050237152139206
NCT00097903,Trial of Oral Karenitecin in Patients With Solid Tumors and Lung Cancer,0.0007403179533815283,0.001032023119262768
NCT00097851,Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC),0.0007491195785520205,0.0007835105382307927
NCT00031785,Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer,0.0007666506850752103,0.0005870280785973862
NCT01408212,Effectiveness of Additional Acupuncture Therapy for Lung Cancer Patients,0.0007283625889190575,0.0008884298389011558
NCT01456429,Assessment of Invasive Mediastinal Staging in cN1 Lung Cancer.,0.0005272379121169054,0.00045378157336213126
NCT01429766,A Prospective Study of Variation in Breath Holding Times at Various Phases of Respiration During the Course of Radiotherapy Including the Effect of Respiratory Training in Lung Cancer Patients,0.0006495998073692904,0.0005215444925258021
NCT01427946,Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung Cancer,0.0006506776458241934,0.0007970583109842553
NCT01454102,"Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012)",0.0007142537100214047,0.0006693631282366739
NCT01460472,Immunotherapy With Racotumomab in Advanced Lung Cancer,0.0006094935403786208,0.0006939657929141876
NCT01465854,French Biological Observatory on Lung Cancer in Never Smokers,0.0006465111539529463,0.00044524571353690175
NCT01419587,Ketogenic Diet With Chemoradiation for Lung Cancer (KETOLUNG),0.0006445872157044082,0.0008169880952282543
NCT01466946,Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients,0.0005952589085518511,0.0007849571008813034
NCT01466647,A Study of the IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin to Treat Non-small-cell Lung Cancer (NSCLC),0.0005508072862510968,0.0006274469099334624
NCT01421953,Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers,0.0006302484926342187,0.0006373667298648491
NCT01407822,Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung Cancer,0.0006921939690260701,0.0006903198564003173
NCT01433172,Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung Cancer,0.0005549625098181984,0.0006797843659341423
NCT01433263,Clinical Study of BYM338 for the Treatment of Unintentional Weight Loss in Patients With Cancer of the Lung or the Pancreas,0.0006694919830031788,0.000878080943875899
NCT01482182,"Predictive Value of FDG PET/CT, DWI and DCE-MRI Scans for Non-small Cell Lung Cancer Patients Receiving Chemotherapy",0.0007146179714928136,0.0007644384762845286
NCT01494883,Mindfulness for Lung Cancer Patients and Partners,0.0009090505037470208,0.000816377712633763
NCT01441349,Irinotecan/Cisplatin With or Without Simvastatin in Chemo-naive Patients With Extensive Disease-small Cell Lung Cancer,0.0007020779858073569,0.0008019397798149161
NCT01444118,A Randomized Trial to Study the Safety and Efficacy of EGF Cancer Vaccination in Late-stage (IIIB/IV) Non-small Cell Lung Cancer Patients,0.0007817598600791515,0.0008476733203322224
NCT01411098,"Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery",0.0007482485184348577,0.0008429746469698346
NCT01493843,Study Evaluating the Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without GDC-0941 in Patients With Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer,0.0008176348315953643,0.0007945902479328273
NCT01457469,Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer,0.0006385901551358556,0.0006842206556607295
NCT01452971,A Study of the Interaction Between Tumor Susceptibility Gene Glycine N-methyltransferase (GNMT) and Lung Cancer,0.0005611118183752911,0.0004832166207859292
NCT01443078,"Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)",0.0007676276686150374,0.0008421863891787082
NCT01416688,"S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride",0.0005549626892869859,0.0005144990022048769
NCT01481259,Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer,0.0005917301433190616,0.0007752939430474404
NCT01424709,Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC),0.0007648740369635902,0.0007006513072559214
NCT01497041,"A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment",0.0007741518896696216,0.0007909446760452914
NCT01415011,Efficacy and Safety Study of Afatinib to Treat Lung Cancer Patients,0.0008320591283934779,0.0008921394164952691
NCT01487603,Feasibility of Evaluating Gene Alteration Analysis Using Samples Obtained by EBUS-TBNA in Patients With Lung Cancer,0.0009086593654929983,0.0006779320105456131
NCT01473693,Changes in Brain Structure Related to Systemic Chemotherapy Treatment: A Prospective Study in Individuals Diagnosed With Non-small Cell Lung Cancer Utilizing High-resolution Structural Magnetic Resonance Imaging,0.0006579873193419529,0.0006465747122588744
NCT01413737,Postoperative Results of Surgical Treatment of Lung Cancer After 30 Days,0.0005914153540739871,0.0008733627204992947
NCT01498562,Phase II Study of Gefitinib Plus Nimotuzumab Versus Gefitinib in Non-small Cell Lung Cancer,0.000726581049735306,0.0006184139470210763
NCT01498055,Autologous CIK Cells Infusion for the Treatment of Lung Cancer: a Randomized Controlled Study,0.0005185975661951084,0.0007506039053510828
NCT01296113,Chemotherapy for Lung Cancer in HIV-positive Patients,0.0007672370282716577,0.0008163037940383374
NCT01284348,Study of ACE-011 to Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer,0.0008657061204988177,0.000931938321871011
NCT01221077,Study of Erlotinib (Tarceva®) in Combination With OSI-906 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) Gene,0.0008588723852073339,0.000815167884047757
NCT01287754,A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Who Present EGFR Mutations,0.0008381365559224594,0.0007515401847962505
NCT01287962,Apatinib in the Treatment of Advanced Non-squamous Non-small Cell Lung Cancer,0.0007448635659491196,0.0007800405000813721
NCT01270399,Targeting ER-Golgi Homeostasis in an Advantageous Therapeutic Strategy in Lung Cancer,0.0005008334195599057,0.0003897245158598774
NCT01270386,A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer,0.0008762814477750056,0.0007889458999102936
NCT01213745,The Use of a Quality of Life Questionnaire in Patients With Lung Cancer,0.0007300027676482337,0.0007779675339402706
NCT01266512,Concurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small-cell Lung Cancer,0.0004782312796104046,0.0003878584863113134
NCT01261585,Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT,0.0007278147673135712,0.0004947564281011783
NCT01259284,Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer,0.0005648899125229676,0.0005423767210524911
NCT01282450,Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC),0.0007634156760578028,0.0008826582050655233
NCT01282151,TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung Cancer,0.0006542227579223254,0.0007220431628112695
NCT01210378,Nitroglycerin in Non-small Cell Lung Cancer,0.0009188561142156019,0.0007137279782253674
NCT01219348,IDO Peptid Vaccination for Stage III-IV Non Small-cell Lung Cancer Patients.,0.0006445759701761828,0.000527519805060791
NCT01203735,Valproic Acid With Chemoradiotherapy for Non-Small-Cell Lung Cancer,0.0007346308838766268,0.0005472356871620623
NCT01246297,Effect of Pulmonary Rehabilitation in Lung Cancer Survivors,0.0009056996849606738,0.0005207584439560432
NCT01280448,"The Correlation Between Lung Cancer Susceptibility, Drug Response and Genetic Polymorphism",0.0004722573486934903,0.0005083617203758081
NCT01281787,PREvention of Atrial Fibrillation in patientS Undergoing thorAcic surGEry for Lung Cancer,0.0009033750323444962,0.000442816729416991
NCT01291017,"Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC.",0.0006442932961891397,0.0008116258217519165
NCT01262560,Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer,0.0006038913442779419,0.0005037330821402532
NCT01262820,Pazopanib In Stage IIIB/IV NSCLC Lung Cancer After Progression on First Line Therapy Containing Bevacizumab,0.0004801170463274984,0.0005556950029912546
NCT01211483,Study of Erlotinib With or Without Investigational Drug (U3-1287) in Subjects With Advanced Non-small Cell Lung Cancer,0.0007381559273059921,0.0008117590612289277
NCT01211002,Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC),0.0007151814260528326,0.000908304007973496
NCT01240447,Immunotherapy With Racotumomab Versus Support Treatment in Advanced Non-small Cell Lung Cancer Patients,0.000779512383004738,0.0008234293022783092
NCT01263886,Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer,0.0007237756884597653,0.00078253013885365
NCT01297491,Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer,0.0009655747409684942,0.0008739017084811111
NCT01218594,Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer,0.0006261967466604056,0.0007550829818331886
NCT01274468,Tumor Markers in Lung Cancer,0.0006748358283762872,0.0008814605256519327
NCT01244191,"ARQ 197 Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer",0.0005916455254248683,0.0006402224599559037
NCT01257308,Research of the EML4-ALK Gene Expression in the Pleural Effusion or Tumor Tissue From Lung Cancer Patients,0.0006022210618086987,0.0008519269431874139
NCT01255059,GWAS Research of Lung Cancer in Tianjin,0.0017222839564628085,0.0011442123686408868
NCT01207011,Amrubicin (AMR) Trial in Patients With Non-small Cell Lung Cancer,0.0009371887942508499,0.0010430747368003785
NCT01207063,Adaptive Radiotherapy in Non-small Cell Lung Cancer (NSCLC),0.0008138578456082995,0.0006772653713733365
NCT01201044,Study to Investigate Bronchial Arterrial Infusing (BAI) Plus Three-dimensional Conformal Radiotherapy (3DCRT) in Local Advanced Non-small Cell Lung Cancer (NSCLC),0.000715579620608962,0.0010371732068269396
NCT01230710,A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Following 4 Cycles of Platinum-based Chemotherapy Without Disease Progression,0.0008571222103745206,0.0008174784447722407
NCT01278888,"Minimally Invasive or Open Surgery for Lung Cancer: Pain, Quality of Life and Economy.",0.00046732367616888495,0.0005276289457958304
NCT01258478,Lung Cancer Rehabilitation Study,0.0007752128143911633,0.0005699922082938453
NCT01258127,Pemetrexed/Carboplatin vs Vinorelbine/Carboplatin in Patients With Completely Resected Non-small Cell Lung Cancer (NSCLC),0.0007320562243748518,0.0006978274388321437
NCT01290809,Prophylactic Cranial Irradiation (PCI) Cognitive Tests in Non-small Cell Lung Cancer (NSCLC) Patients,0.0007685408519431858,0.0006978149814242627
NCT02941003,Precision Diagnosis for Intraoperative Frozen Section of Early Stage Lung Cancer,0.0005037734350252248,0.000509780698204933
NCT02921191,"Descriptive Analysis of G-CSF Use in Patients With Breast Cancer, Lung Cancer, or Lymphoma Treated",0.0006337265094167249,0.0005719657687631884
NCT02917369,Integrative Analysis of Large-cell Lung Cancer,0.0017222839564628085,0.0024708010121151443
NCT02907606,Urinary Circulating Tumor DNA Detection in Non-small Cell Lung Cancer: a Prospective Study,0.0007393730650044234,0.0008522607396907409
NCT02973789,Effect of Tumor Treating Fields (TTFields) (150 kHz) as Second Line Treatment of Non-small Cell Lung Cancer (NSCLC) in Combination With PD-1 Inhibitors or Docetaxel (LUNAR),0.0006082079503218072,0.0007201614438866229
NCT02997449,Complete Endosonographic Intrathoracic Nodal Staging of Lung Cancer Patients in Whom SABR is Considered,0.0007258814485484027,0.0008879666280498812
NCT02954809,"Effects of Bright Light Therapy on Fatigue, Sleep and Circadian Activity Rhythms in Lung Cancer Survivors",0.00043584428202372096,0.0005530792933817279
NCT02980809,Topotecan Plus Apatinib Versus Topotecan Alone as Second-line Therapy in Small-cell Lung Cancer,0.0005066867238991923,0.0008042275560056145
NCT02938546,18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study,0.0006482897145009405,0.0006632354406733112
NCT02904954,Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage IB and II Non-small Cell Lung Cancer,0.000675586875923094,0.0008291647876179872
NCT02968979,Non-interventional Study to Assess the Frequency of Cachexia in Patients With Non-small Cell Lung Cancer.,0.0007813591096063812,0.000883838418602229
NCT02956551,Neoantigen-primed Dendritic Cells (DC)- Pre-activated T (PreT) Cell Therapy for Refractory Non-small Cell Lung Cancer,0.0007366158160501143,0.0010188087875224697
NCT02992353,"Single-port, Two-port Versus Three-port VATS on Non-small Cell Lung Cancer",0.0007370446425554889,0.0006560474005942242
NCT02994576,Atezolizumab as Induction Therapy in Non-small Cell Lung Cancer,0.0007366152303225887,0.0006818480388513787
NCT02936323,PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers,0.0007093862007419629,0.0006824626991879864
NCT02936804,Precision Diagnosis and Therapy for Early Stage Lung Cancer,0.0006173504095406827,0.000540094680258788
NCT02978521,Pulmonary Rehabilitation in Advanced Non-small Cell Lung Cancer Patients,0.0008767346649503764,0.0007855985649195285
NCT02931461,Interest of Procore Needle® for Diagnosis of Lung Cancer,0.0005328877267547523,0.0004890485548291648
NCT02984761,Veterans Affairs Lung Cancer Or Stereotactic Radiotherapy,0.0009045478929853414,0.0008212410984269457
NCT02963610,Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer,0.0007904006521100352,0.0007926476889318422
NCT02989974,Kentucky LEADS Collaborative: Lung Cancer Survivorship Care Program,0.0009068994171126162,0.0004655947866041387
NCT02961270,Icotinib in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutation,0.001187884138916485,0.0012477334321986965
NCT02965391,Dynamic Changes of Circulating Tumor DNA in Surgical Lung Cancer Patients,0.0006669746032988835,0.0006636667415246419
NCT02974933,Apatinib Mesylate Combined With Pemetrexed in the Treatment of Pretreated Advanced Non-squamous Non-small Cell Lung Cancer,0.000691427955242776,0.0008506003418329641
NCT02991924,Risk Factors of Medistinal Metastasis in Endoscopic Staging of Lung Cancer,0.0005244096259118027,0.0004625059365330492
NCT02933294,Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early Stage Lung Cancer,0.0005641994835318872,0.0004835829245980459
NCT02927340,A Study of Lorlatinib in Advanced ALK and ROS1 Rearranged Lung Cancer With CNS Metastasis in the Absence of Measurable Extracranial Lesions,0.0005691195338846895,0.0007750533061529683
NCT02976116,A Phase II Study of Fruquintinib in Combination With Gefitinib in Patients With Advanced Non-small Cell Lung Cancer,0.000832663862456475,0.0007810918793751684
NCT02922777,Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer.,0.001319625915519793,0.0009383907207677842
NCT02995889,FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer,0.000599081322967798,0.0007359788252288027
NCT02959619,Ensartinib in Non-small Cell Lung Cancer Patients With Positive ALK,0.0008125167503204235,0.0009976723819322385
NCT02942043,Bevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung Cancer,0.0006834018593475076,0.0009187942257637099
NCT02971501,Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases,0.0007183147775476926,0.0007648361329527048
NCT02955758,Pembrolizumab in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer,0.0008331435603087669,0.0009765242963645166
NCT02955290,CIMAvax Vaccine and Nivolumab in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer,0.0007711024501771473,0.0008382428215309297
NCT02972177,Transbronchial Ablation for Peripheral Lung Cancer,0.0009027881993710075,0.0009126988686409914
NCT02966769,N2 Lung Cancer Project: Neoadjuvant Treatment Followed Surgery Versus Chemoradiation,0.0004888690920888583,0.0006510335162755703
NCT02947386,Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0008029023994225695,0.0007782315052817574
NCT02967133,A Study of Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung Cancer,0.0007266402232508401,0.0007053709828410633
NCT02937818,"A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer",0.0008317934937245131,0.0008512405286779669
NCT02916147,Effect of Different Anesthetics on the Change of Alarmins in Lung Cancer Patients Receiving Pulmonary Lobectomy,0.000589278851424114,0.0005542750870038055
NCT02916745,Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung Cancer,0.0004386771303078469,0.0006251564008987159
NCT02538380,EUS-B-FNA vs EUS-FNA for Left Adrenal Gland Analysis in Lung Cancer Patients,0.0007261720790270078,0.001173763530969847
NCT02500810,Monosialoganglioside Preventing Neurotoxicity Induced by Albumin-bound Paclitaxel Chemotherapy in Lung Cancer Patients,0.0006107684268103566,0.0006821027471438069
NCT02589522,VX-970 and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases From Non-small Cell Lung Cancer,0.0007768297062280427,0.0008313748600149211
NCT02507518,Role of PET Scan in the Evaluation of Early Response to Maintenance Treatment in Advanced Non-small-cell Lung Cancer,0.0005321576076718307,0.0008220948149129109
NCT02542930,Abscopal Effect for Metastatic Non-small Cell Lung Cancer.,0.0007608782471622307,0.0008385813457346611
NCT02542293,Study of 1st Line Therapy Study of Durvalumab With Tremelimumab Versus SoC in Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE).,0.0006741381496543851,0.0006783764963615024
NCT02566993,"Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin (DOX) Versus Cyclophosphamide (CTX), Doxorubicin (DOX) and Vincristine (VCR) (CAV) or Topotecan as Treatment in Patients With Small-Cell Lung Cancer",0.0007146048119300208,0.0005909926467509207
NCT02578680,Study of Platinum+Pemetrexed Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Non-squamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189),0.0006818137637166522,0.0007100714962439077
NCT02504801,Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD,0.0007254864467442191,0.000525149010505126
NCT02504372,Study of Pembrolizumab (MK-3475) vs Placebo for Participants With Non-small Cell Lung Cancer After Resection With or Without Standard Adjuvant Therapy (MK-3475-091/KEYNOTE-091),0.0006318449161700236,0.0006819334473137675
NCT02504346,"AZD9291, an Irreversible EGFR-TKI, in Relapsed EGFR-mutated Non-small Cell Lung Cancer Patients Previously Treated With an EGFR-TKI, Coupled to Extensive Translational Studies",0.0008092494709300624,0.0007984684114875982
NCT02570815,Near-Infrared Fluorescence Guided Robotic Pulmonary Segmentectomy for Early Stage Lung Cancer,0.00046248350257782725,0.0004134969025512544
NCT02573506,Study of Consolidation Chemotherapy For Bulky Local Advanced None-small Cell Lung Cancer,0.0007227053338358595,0.0008170780227899562
NCT02556593,IMRT Combined With Erlotinib for EGFR Wild Type Non-small Cell Lung Cancer With 4-10 Brain Metastases,0.0006599932468223032,0.000820694978047434
NCT02502318,Medicoeconomic Evaluation of Two Surgical Techniques for Lobectomy in the Lung Cancer,0.0005628781304719886,0.0005999303219617735
NCT02502695,A Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS),0.0008305494507450354,0.0006371644056189112
NCT02505685,Dynamic PET CT as a Tool for Treatment Efficacy Monitoring in Lung Cancer,0.0005809762757903089,0.0007850828834594854
NCT02588261,A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations,0.0008332657923251413,0.0008670995909918478
NCT02520778,Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer,0.0007672944793923116,0.0008424214756789034
NCT02540174,Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer : Interest of an Addiction Treatment,0.0005837700672319492,0.0005954469238516911
NCT02540824,Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung Cancer,0.0007242675567193203,0.0007537756430845716
NCT02551211,Association Between Circulating Immune Cells and the Tumor Immune Contexture in Resectable Non-small Cell Lung Cancer,0.0006036353088755154,0.0007444445974985818
NCT02513355,Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research,0.0006563560996443778,0.0005785388584024294
NCT02579005,Radio-Immuno-Modulation in Lung Cancer,0.0006396622383448269,0.0005362051992421151
NCT02577393,Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial Radiotherapy,0.0006612202733188929,0.0006153730306843066
NCT02596490,Couple-Based Meditation for Metastatic Lung Cancer Patients and Their Partners,0.0006554249421353892,0.00041385183096417016
NCT02596958,Safety and Efficacy Study of Avastin in Locally Advanced Metastatic or Recurrent Non-small Lung Cancer (NSLC) Participants,0.0006408804986419067,0.0006764335787166393
NCT02572843,Anti-PD-L1 in Stage IIIA(N2) Non-small Cell Lung Cancer (NSCLC),0.0008121533518863521,0.0006108379425769043
NCT02511288,LIquid BIopsies in Lung Cancer (LIBIL),0.0017222839564628085,0.0006235424205391149
NCT02535325,"Methoxyamine, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung Cancer",0.0007518958573292863,0.0008613756651299532
NCT02535338,Erlotinib Hydrochloride and Hsp90 Inhibitor AT13387 in Treating Patients With Recurrent or Metastatic EGFR-Mutant Non-small Cell Lung Cancer,0.0007610842317283816,0.0007447564495814201
NCT02549261,Nimotuzumab in Combination With Radiochemotherapy for Patients With Stage IIIA/IIIB Non-small Cell Lung Cancer,0.0007502294229237912,0.0007664371717243229
NCT02522910,An Open-label Phase Ib/II Study of BAY 1000394 (Roniciclib) in Combination With Docetaxel in Second- or Third-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC),0.0008775912193069465,0.0008023221220037085
NCT02546986,Safety and Efficacy Study of CC-486 With MK-3475 to Treat Locally Advanced or Metastatic Non-small Cell Lung Cancer,0.0008127973237002255,0.0007295239587113009
NCT02531464,Intervention to Improve Supportive Care for Family Caregivers of Patients With Lung Cancer,0.0005924443756537935,0.0005897746642536981
NCT02531737,Nintedanib (Vargatef®) Plus Docetaxel in Second Line of Treatment in Patients With Lung Cancer,0.0006079497132768323,0.0008694438952949704
NCT02515435,The Efficacy and Safety of Apatinib in Heavily Pretreated Advanced Non-squamous Non-small Cell Lung Cancer,0.0008188961464882202,0.0007459478468443174
NCT02515760,Tumor-specific T Cells in Lung Cancer,0.0005403401353886271,0.000583428725277743
NCT02568033,Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer,0.0006402280090136387,0.0007812553094329102
NCT02528942,Feasibility Study Incorporating Lung Function Imaging Into Radiation Therapy for Lung Cancer Patients,0.0006017855585383033,0.0006459987736083718
NCT02599454,Atezolizumab and Stereotactic Body Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer,0.0008093473908892265,0.0008463431736538663
NCT02595944,Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer,0.0007741461183547922,0.0008685719967447078
NCT02595450,A Non-interventional Trial of Erlotinib (Tarceva) Metastatic Non-small Cell Lung Cancer,0.0006299858427424324,0.0007666276644457765
NCT02595840,"A Prospective, Multiparametric Biomarker Study to Identify Predictors of Treatment Response and Resistance in Patients With EGFR-mutated Non-small-cell Lung Cancer Receiving Maintenance Therapy With Either Afatinib or Pemetrexed With the AIO-TRK-0114 Study (MARBLE)",0.0006688886008597722,0.0006255131653694402
NCT02580708,A Phase 1/2 Study of the Safety and Efficacy of Rociletinib When Administered in Combination With Trametinib in Patients With Activating EGFR Mutation-positive Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC),0.0008593411771136401,0.0008307547177037348
NCT02590965,A Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer,0.0008000976535523832,0.000681170840969706
NCT02581943,Effect of Pembrolizumab With or Without Carboplatin and Paclitaxel on Immune Response in Patients With Recurrent or Stage IIIB-IV Non-small Cell Lung Cancer,0.0007407956995190194,0.0008632802849396863
NCT02581787,SABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung Cancer,0.0006184804149238244,0.0007050526960334446
NCT02562027,SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer,0.0006347062622110671,0.0006136955827444822
NCT02575560,Weekly Use First-generation EGFR-TKI in the Treatment of EGFR-TKI Acquired Resistance Non-small Cell Lung Cancer (NSCLC),0.0006225319162710454,0.000715139367574179
NCT02597738,A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine,0.0005232629040043636,0.0005147016891237413
NCT02525653,Albumin-Bound Paclitaxel and Gemcitabine in Patients With Untreated Stage IV or Recurrent Squamous Cell Lung Cancers,0.0007230989355076486,0.0008172805576628184
NCT02525757,MPDL3280A With Chemoradiation for Lung Cancer,0.0009093020855091531,0.0006332292656564598
NCT02501668,The Prevalence of Lung Cancer in Patients With Interstitial Lung Disease,0.0009086593654929983,0.000414568620034882
NCT02503722,TORC1/2 Inhibitor INK128 and EGFR Inhibitor AZD9291 in Treating Patients With Advanced EGFR Mutation Positive Non-small Cell Lung Cancer After Progression on a Previous EGFR Tyrosine Kinase Inhibitor,0.000751606696114384,0.0008216604203486023
NCT02503358,Selumetinib and Paclitaxel as Second-Line Treatment in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer,0.0007610608883320622,0.0008014461124103167
NCT02523404,HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Lung Cancer,0.0005727608776588938,0.0009122162800011692
NCT00685750,Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma,0.0006010278734397328,0.0007241136029776347
NCT00687297,Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung Cancer,0.0007475231795022038,0.0006857393178464444
NCT00687986,Trial of Either Surgery or Stereotactic Radiotherapy for Early Stage (IA) Lung Cancer,0.0005159357876560141,0.0006391243244549346
NCT00621361,"Phase I Safety and Tolerability Study of Cediranib (RECENTIN™, AZD2171) in Combination With Chemo in First Line Lung Cancer Patients",0.0006352030171240909,0.0006605820126133077
NCT00676507,Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy,0.0006688563245436632,0.0007055278246274741
NCT00614484,Chemotherapy and Proton Radiation for the Treatment of Locally Advanced Lung Cancer,0.0006310087814576465,0.0008940367839826031
NCT00633568,Randomised Study of Concomitant Radiochemotherapy in Non-small Cell Lung Cancer,0.0008360892808216007,0.0007056357286602723
NCT00633724,Multiple-Vaccine Therapy in Treating Patients With Non-small Cell Lung Cancer,0.000940121005038864,0.0007697971754104696
NCT00662311,"Vorinostat, Paclitaxel, and Radiation Therapy in Treating Patients Unable to Tolerate Cisplatin With Stage III Non-Small Lung Cancer That Cannot Be Removed By Surgery",0.0006208105520032061,0.0008475850376103377
NCT00652340,APRiCOT-L: Study to Evaluate Efficacy and Safety of Apricoxib With Erlotinib in Patients With Non-small Cell Lung Cancer,0.0007998853437468732,0.0007621956236352094
NCT00636571,Feasibility of Exercise With Post-Op Lung Cancer Patients,0.000911420577604172,0.0005680259647982522
NCT00673049,"Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer",0.0009424897300104859,0.0006850238805997739
NCT00673283,Early Detection of Lung Cancer Via Bi-plane Correlation Chest Imaging,0.0005306144728391093,0.0003107218725148899
NCT00600821,A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.,0.0007115331561347803,0.000730110085259246
NCT00600015,Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC),0.0006604492371727553,0.0006727609496500672
NCT00611598,DNA Repair and Genetic Susceptibility to Lung Cancer,0.0005260565079931646,0.00048608290620810783
NCT00683904,Ixabepilone in Combination With Carboplatin in Patients With Non-small Cell Lung Cancer,0.0007723401701858785,0.0009158439653140956
NCT00657423,Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC),0.0006680160103995861,0.0007102760128395189
NCT00681512,The Effect of Berries on Lung Cancer Tumors,0.000930495827766427,0.001052348855740291
NCT00682383,Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC),0.000645364041729111,0.0005490997495412756
NCT00684385,An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and Neck,0.0007088185594080694,0.0007039682941764516
NCT00603057,Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer,0.00045412511657567944,0.0006973755277281366
NCT00603538,"Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer",0.0006160485056179516,0.0007649363836628895
NCT00635596,"Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer",0.0006155955129282725,0.0005503802879577312
NCT00658580,Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer,0.0006477393517389826,0.0006936026185039158
NCT00656136,BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1),0.0007126704627411376,0.0006535861717859308
NCT00691132,Phenethyl Isothiocyanate in Preventing Lung Cancer in Smokers,0.0006465119272878015,0.00044183603652497215
NCT00639067,Breath Test for Early Detection of Lung Cancer,0.0006432714527044399,0.0006115881654900756
NCT00675597,"Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer",0.0007259900270214967,0.0007193733974491113
NCT00690924,Calcitriol in Preventing Lung Cancer in Smokers and Former Smokers at High Risk of Lung Cancer,0.0005294028829921717,0.00041620684793002797
NCT00601796,"Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer",0.0006077579860223774,0.0006838992274627966
NCT00661778,A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung Cancer,0.0008573309054351728,0.0008259096764596101
NCT00693836,"Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region",0.0007284700178311511,0.0004845832087806221
NCT00622193,Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer,0.0010398847775535747,0.001434921921843954
NCT00622349,Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer,0.0007506980543264091,0.0007414456609417957
NCT00698815,Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007323974251909281,0.0008205559941776675
NCT00666692,"A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC)",0.0007331515054229831,0.0007921584140269808
NCT00686322,Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC),0.0005233359875628835,0.000619229976777971
NCT00380666,The Utility of PET/CT in the Planning of Stereotactic Body Radiotherapy for Non-small Cell Lung Cancer,0.0006479419079677594,0.0004921173689043105
NCT00398970,Utility of Endobronchial Ultrasound in the Investigation of Suspected Lung Cancer.,0.000661116271590375,0.0005545545562419017
NCT00349492,A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer,0.0005211879441248701,0.0005869524907756306
NCT00349102,Prevention of Radiation Pneumonitis After Three-dimensional Conformal Radiation Therapy (3D-CRT) in Patients With Non-small-cell Lung Cancer,0.0006681928103763711,0.0005865998795309566
NCT00349089,Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy,0.0006931842888834366,0.0005344462448153536
NCT00338481,"""Red Morphine Drops"" for Symptomatic Treatment of Dyspnoea in Lung Cancer",0.00046964501922073187,0.0005122079826518929
NCT00373204,Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere),0.0006474920631927969,0.0007081455049358992
NCT00347412,Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer,0.0006854529782689582,0.0007484641421913079
NCT00303901,Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery,0.0006086665278961676,0.0007088658737953724
NCT00340405,"Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China",0.0005205760130068985,0.0005255451195886935
NCT00340340,Genetic Epidemiology of Lung Cancer and Smoking,0.0005261569742466794,0.000498445669518212
NCT00340847,Construction and Use of Lung Tumor Microarray for the Analysis of Gene Expression in Lung Cancer,0.0004626441190294207,0.0005746736984783922
NCT00368927,Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia,0.0004684429258372891,0.00038596044178021877
NCT00315185,"Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer",0.0005985321395029657,0.0005946578649087762
NCT00326378,Efficacy Study of Additional Chemotherapy After Concurrent Chemoradiation in Non-small Cell Lung Cancer,0.0007495981235016882,0.00084679212413458
NCT00363428,Lung Rehabilitation in Treating Patients With Chronic Obstructive Pulmonary Disease Who Are Undergoing Surgery for Lung Cancer,0.0006531354768872157,0.0004470512168165774
NCT00363805,Green Tea or Polyphenon E in Preventing Lung Cancer in Former Smokers With Chronic Obstructive Pulmonary Disease,0.000467723747241924,0.00038143487660400417
NCT00345059,The DISTAL-2 Study: Docetaxel Alone or in Combination in Second-line Treatment of Advanced Non Small-Cell Lung Cancer,0.0007326608467426272,0.0007484651543471749
NCT00345891,Quit Smoking Program for Lung Cancer Patients' Families (The Family Ties Project),0.0005902829954119445,0.0006403452287646274
NCT00397124,The Role of the Vagus Nerve in Tumor-to-Brain Communication in Lung Cancer Patients,0.0006006859935700233,0.0006097939920719512
NCT00372788,"AZD6244 Versus Pemetrexed (Alimta®) in Patients With Non-small Cell Lung Cancer, Who Have Failed One or Two Prior Chemotherapy Regimen",0.0007481262072704211,0.0008398454258928635
NCT00342836,Analysis of Tissues From Patients in Trial of Myo-Inositol to Prevent Lung Cancer,0.0006380750967754156,0.0005851809767219819
NCT00342264,A Nested Case-Control Study of Lung Cancer and Diesel Exhaust Among Non-Metal Miners,0.0005485588749306892,0.00044280051036217947
NCT00316225,Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen,0.0006324759384268752,0.0007581735721329997
NCT00365105,"Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer",0.0005479992609644664,0.0003962739397562844
NCT00365963,Web-based Intervention for Lung Cancer Patients and Their Informal Caregivers,0.0009159942760064709,0.0005099349958309502
NCT00329472,Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small Cell Lung Cancer,0.0007419318783014197,0.0007881039849919409
NCT00313690,Cancer Treatment Followed by Surgery for Early Stage Non-small Cell Lung Cancer,0.0006879439728203732,0.0006946883145604088
NCT00364624,Adrenal Function in Patients With Newly Diagnosed Lung Cancer,0.000643881919669883,0.0005087146327926871
NCT00364780,Study of XL647 in Subjects With Non-Small-Cell Lung Cancer,0.0010532469033602801,0.0006645637291128567
NCT00325494,"A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer",0.0005096400220468806,0.0004825977511397356
NCT00330746,CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung Cancer,0.0006948583672369105,0.0008445167328042802
NCT00391248,Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation Therapy for Non-small Cell Lung Cancer (PEARL),0.0006883457846517797,0.0006924271251077199
NCT00312819,Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung Cancer,0.0004644313738513992,0.0006770811710945364
NCT00312377,ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer,0.0006580875212270845,0.0008303384225616039
NCT00341380,Prevention of Tumor Spread Due to Lung Cancer Surgery,0.0005615029031569258,0.000687808743317417
NCT00341835,Genetic Epidemiology of Lung Cancer,0.0006441103202166876,0.0005530483711513972
NCT00322751,Concurrent Radiotherapy With Weekly Topotecan for Primary Treatment of Inoperable Localized Non-small Cell Lung Cancer,0.0007094508227946013,0.0006023111555203852
NCT00300586,IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer,0.0008772153731100852,0.0006765197971696392
NCT00390806,Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer,0.000505466994288446,0.0006364475445952422
NCT00339859,"DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer",0.0009027888880530113,0.0008248208850718061
NCT00324805,"Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery",0.0007579557801246031,0.0008500976964300859
NCT00791336,Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung Cancer,0.0006761806708098615,0.0009755451230911975
NCT00723957,A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung Cancer,0.0007007690059255602,0.0007672017090496291
NCT00794547,Phase I/II Calcitriol in Lung Cancer,0.0009027883272514155,0.0008807611030266821
NCT00741247,Mediastinal Staging of Lung Cancer With EBUS-TBNA and EUS-B-FNA,0.0006412538089369963,0.00045979589466744976
NCT00741988,Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer,0.0006686682431488897,0.000714999306877874
NCT00783705,Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia,0.00046891560485996564,0.00039525360778004876
NCT00749346,NovoTTF-100L in Combination With Pemetrexed (Alimta®) for Advanced Non-small Cell Lung Cancer,0.0006442458617042865,0.000765846833104653
NCT00749567,Combination of Erlotinib and Bevacizumab as Second-line Treatment in Patients With Non-small Cell Lung Cancer,0.0007741498317944334,0.0008423157289696463
NCT00738881,Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0007639053609048447,0.0008166367078847605
NCT00738387,A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer,0.0007033741281711361,0.000866063344054319
NCT00733252,Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease,0.0005220324014935047,0.0004307079172650012
NCT00724581,Amiodarone Prophylaxis for Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer,0.0006045711656176923,0.00047681302729302437
NCT00735878,Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients With Advanced Lung Cancer,0.0007372808096183582,0.0007205986836682674
NCT00735696,A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung Cancer,0.0007542821597586477,0.0008240471066115688
NCT00798720,Vorinostat and Bortezomib as Third-line Treatment in Advanced Non-small Cell Lung Cancer,0.0006816675672643592,0.0008169130841275569
NCT00707304,Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer,0.001187884138916485,0.0010272647575075196
NCT00706862,Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer,0.0008378347142568804,0.0008391649331953301
NCT00745160,Survey and Blood Sample Collection for Patients With Lung Cancer Who Never Smoked Cigarettes,0.0005853354157041008,0.0006221294506932612
NCT00702975,Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic Therapy,0.0008635226145032006,0.0008150653679320341
NCT00752076,Detection of EGFR Mutation in Malignant Pleural Effusion of Lung Cancer Patients and Cancer Cell Lines Establishment,0.0007489264144375734,0.0009785729552766243
NCT00752115,Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer,0.0007739639170287047,0.0007601035997249558
NCT00717353,Genetic Polymorphisms in UGT1A6 and UGT2B7 in Asian Population: Association With Lung Cancer Phenotype,0.0005248461269705284,0.0004997687620545577
NCT00717795,Physical Activity Intervention for Lung Cancer Survivors,0.0005342109021034443,0.000550136928659197
NCT00717002,Detection of EGFR Mutations in the Blood of Patients With Non-small Cell Lung Cancer: a Feasibility Study,0.0007476757385299152,0.0007867754233736579
NCT00799240,MK-0646 Insulin Growth Factor 1 Receptor Antibody in Stage IIIb or IV Metastatic Non-Squamous Lung Cancer,0.00046427640119106205,0.0006567294753700191
NCT00701870,Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non‑Small Cell Lung Cancer,0.0008116578090792472,0.0008487082061504776
NCT00737867,Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer,0.0006681287257797406,0.0008142275006447351
NCT00732810,SCH 727965 in Patients With Advanced Breast and Lung Cancers (Study P04716),0.0007877112056790183,0.0007229244897102767
NCT00721981,An Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing Chemotherapy,0.000789153434070185,0.0008051342910801883
NCT00708812,Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer,0.0007874707155012555,0.0006148779486998089
NCT00705549,"Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung Cancer",0.0007434169882369748,0.0007731384165935955
NCT00425191,Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer.,0.0006440801895487849,0.0007255342451220601
NCT00425022,VATS Lobectomy for Clinical Stage IB or II Lung Cancer,0.0005040803704535281,0.000584623244834591
NCT00466466,Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients,0.0006687351309395982,0.0007238824125189483
NCT00465907,"Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung Cancer",0.0005820958163093878,0.0007155995882810782
NCT00442754,Dendritic Cells in Lung Cancer,0.000909847444115859,0.0005082676535435067
NCT00491699,Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer,0.0010532469033602801,0.0006719038761165797
NCT00464282,Fluorine-18-α–Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer,0.0006698505012084134,0.0006017497242705908
NCT00457119,"Combination of RAD001 With Carboplatin, Paclitaxel and Bevacizumab in Non-small-cell Lung Cancer (NSCLC) Patients",0.0006358612672587141,0.0007117190614862228
NCT00492843,Loading Dose or Standard Dose of Intravenous Ibandronate in Treating Patients With Lung Cancer and Skeletal Metastasis,0.0005899401257133961,0.000538266908882702
NCT00481624,Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia,0.0006408769575484539,0.000570799754145867
NCT00437749,A Study of CBT-1 and Paclitaxel With Carboplatin in Patients With Advanced Inoperable Non-small Cell Lung Cancer,0.0008573130142247849,0.0007529835926169782
NCT00487760,African American Families and Lung Cancer Study,0.0011026363996239049,0.0005751214745454953
NCT00487669,Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC),0.0007150028430238554,0.0007044719899318853
NCT00431015,"Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC)",0.0006953759450486101,0.0008822285776381178
NCT00409188,Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START),0.0006458688913030033,0.0006720857045476726
NCT00400803,Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer,0.0006410466170690386,0.0008190638013235141
NCT00444015,Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC),0.0006855788217006848,0.0006324511436358451
NCT00440960,Anesthesia in Flexible Bronchoscopy for Lung Cancer Diagnostic,0.0005335075373871497,0.0005783631915498946
NCT00415363,"Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy",0.0006825443027257206,0.0007610394381567289
NCT00422500,Longitudinal Study of Multiple Symptoms in Advanced Lung Cancer,0.0007094027458618452,0.0007019490653670114
NCT00473083,Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer,0.0004837937733712532,0.0004311923152173871
NCT00452413,A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer,0.0005771902535092152,0.0007983879695074266
NCT00452075,Erlotinib as First-line Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) for Patients Unfit for Chemotherapy,0.0008344138094806223,0.0008788635374808555
NCT00402883,"Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer",0.0007570566034825787,0.0007863774661739482
NCT00424853,ADVANCED Phase II Trial of Weekly vs 3 Weekly Docetaxel and Cisplatin Followed by Gemcitabine in Non-small-cell Lung Cancer (NSCLC),0.0005249557217729967,0.0005742737984739736
NCT00462995,Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT),0.0005089364383451196,0.0008115790491924246
NCT00490659,Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes,0.0005944118782327755,0.000689308353391131
NCT00411593,Phase I-II for Patients With Recurrent or Refractory Non-small Cell Lung Cancer (NSCLC),0.000977386875467648,0.0007674880476326217
NCT00406302,Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC),0.0005036440746171227,0.0005208756218697667
NCT00432640,Assessment of Surgical sTaging vs Endoscopic Ultrasound in Lung Cancer: a Randomized Clinical Trial (ASTER Study),0.0005107338797631366,0.0006602123082099431
NCT00416689,Nausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung Cancer,0.0006108718081432427,0.0005692920362229325
NCT00404365,Depression Screening in Patients With Lung Cancer,0.0007263632606591664,0.0005355186734157506
NCT00434174,Safety of Everolimus and Pemetrexed in Lung Cancer Patients,0.0007381748751665472,0.0009478834775477355
NCT00471978,DNA Analysis of Blood and Tissue From Patients With Lung Cancer,0.0006404695525515912,0.0006289016042497511
NCT00460551,Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer,0.0004837390425727302,0.0006295440176761982
NCT00489996,Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung Cancer,0.0006518496622877134,0.0008776561542616704
NCT00482014,"A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer",0.0008157618094350363,0.0009475553006990659
NCT00482118,"Smoky Coal Exposure, Genetic Susceptibility, and Lung Cancer in Non-Smoking Women in China",0.0004674653644287505,0.0004771266144056517
NCT01886573,Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery,0.0006138222520519423,0.0008423791593565748
NCT01862081,"A Dose-escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of GDC-0032 in Combination With Docetaxel or With Paclitaxel in Patients With HER2-negative Locally Recurrent or Metastatic Breast Cancer or Non-small Cell Lung Cancer",0.0007898757354362549,0.0007597046365650312
NCT01862770,Effect of Lung Cancer Diagnoses on Family Behaviors,0.0005334709410604051,0.0005993295007935179
NCT01888510,CT in Diagnosing Patients With Lung Cancer,0.0009226416786634564,0.0008497019774736627
NCT01888601,TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx),0.0009792117667445652,0.0008145739350976227
NCT01893580,Perioperative Rehabilitation in Operation for Lung Cancer,0.0006729563187162703,0.000682883645442728
NCT01877811,"Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors",0.0007005469206409122,0.0006456704075542025
NCT01877902,Study Of Use Of Pemetrexed In Patients With Non-Small Lung Cancer Metastatic In Andalusian Public Health System,0.0006592561782271448,0.0007392099556292243
NCT01852838,The Contribution of Induced Glycolysis to the Exhaled Volatile Organic Compounds' (VOCs) Signature in Lung Cancer,0.0006404633525370686,0.0005267899985194037
NCT01874678,A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer,0.0007983499628293522,0.0007436147804080581
NCT01899989,Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer,0.0009223477786770046,0.0007349637180499377
NCT01828099,LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer,0.0008395773403415867,0.0009660104231951664
NCT01853826,An Open Label Trial of Afatinib (Giotrif) in Treatment-naive (1st Line) or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s),0.0008340864533794164,0.0007791109648254406
NCT01883986,Supportive Care for Patients Newly Diagnosed With Lung Cancer,0.0007375305563988753,0.0005090759699652387
NCT01836575,Alimta® Versus Its Combination With Carboplatin in Advanced Non-small-cell Lung Cancer in Patients Performance Status 2,0.0006483717222808788,0.0008145780426502516
NCT01836679,Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer,0.0006608378859079399,0.0008620644618467077
NCT01836341,Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive Chemoradiation,0.000612883919556212,0.0007626190216987529
NCT01846520,"Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers",0.0005612377810369793,0.0005723861171863547
NCT01855191,SDC for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or Chemoradiation,0.00077059341852462,0.0006305756073358909
NCT01809210,Assess Safety & Efficacy of Selumetinib When Given in Combination With Standard First Line Treatment for Advanced Non-small Cell Lung Cancer,0.0006399350476569855,0.0006771466404116123
NCT01880528,Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer,0.0006682128255808331,0.0007347647407168869
NCT01861197,Phase II Study of Dovitinib for FGFR1 Amplified Squamous Non-small Cell Lung Cancer,0.0007212866382353408,0.001110245746838829
NCT01829113,Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer,0.000624096478983162,0.0008852348342885193
NCT01823094,CTP Imaging of Lung Cancer,0.000914198277554996,0.0003715220244777337
NCT01865903,Nutritional Problems and Changes in Body Composition in Patients With Non-small Cell Lung Cancer (LEKS),0.0007083779692586433,0.0004938940325392362
NCT01820325,Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung Cancer,0.0008115580952105707,0.0007489164174028107
NCT01881906,Exercise in Advanced Stage Lung Cancer Patients,0.0007345463482905965,0.0006046648922986102
NCT01881516,Acupuncture Research on Lung Cancer Patients With Cancer Related Fatigue（CRF）,0.0006404402206787446,0.000644472293270864
NCT01859338,"MRI, Cone Beam CT, and Fan Beam CT in Detecting Soft Tissue in Patients With Prostate and Lung Cancer Undergoing Radiation Therapy",0.0005947572888631051,0.0006254637584643417
NCT01822496,Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer,0.000736402184177263,0.0009134516452929482
NCT01871454,Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers,0.0006186758315017783,0.0005990895522270695
NCT01887769,Body Composition Analysis for Patient With Lung Cancer Using Computed Tomography Image Analysis,0.0006346848007460589,0.0005955777563667277
NCT01885754,Characterization of Peripheral Muscle Function in Patients With Non-small-cell Lung Cancer,0.0007284908334786885,0.0006610035922709018
NCT01837329,Phase I Study of Tetrathiomolybdate in Combination With Carboplatin/Pemetrexed in Metastatic Non-small Cell Lung Cancer,0.0006686565607240172,0.0007646205649765806
NCT01854684,Photodynamic Therapy During Surgery in Treating Patients With Non-small Cell Lung Cancer That Can Be Removed by Surgery,0.0007616763647431959,0.0007734801969017871
NCT01898156,"Two-Part, Open-Label, Multi-Center, Phase 1/2 Study of BIW-8962 as Monotherapy in Subjects With Lung Cancer",0.0005495002994499806,0.0005937764733599276
NCT01851161,Prone Patient Positioning in Reducing Tumor Motion and Improving Breathing Reproduction in Patients With Lung Cancer Undergoing Radiation Therapy,0.0006015072249674123,0.0006224698780628259
NCT01802021,Effect of Astragalus-based Formula: Qingshu-Yiqi-Tang on Modulating Immune Alterations in Lung Cancer Patients,0.0005866547858891537,0.0007266602577247079
NCT01969955,Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer,0.0005930784878113172,0.0009037612381351595
NCT01995188,A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung Cancer,0.0006460912963325328,0.0006727646007489099
NCT01980212,Tumor Relapsed Study of Serum Trxr Activity in Advanced Non-small Cell Lung Cancer,0.0006914618086300957,0.0007690510488685965
NCT01980849,Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer,0.0006066789490931486,0.0004938420568518736
NCT01977209,Gossypol Combined With Docetaxel and Cisplatin Scheme in Advanced Non Small-cell Lung Cancers With APE1 High Expression,0.0004907406429735186,0.0005889748442474685
NCT01937637,Improving Management of Breathlessness in Patients With Lung Cancer,0.0007292715434074991,0.000640569087186731
NCT01950156,Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 Disease Controlled Advanced Non-small Cell Lung Cancer,0.0007241563740219959,0.0007079470309804295
NCT01952860,Hatha Yoga in Lung Cancer Couples,0.0009039511545745213,0.0006434839490545831
NCT01911507,INC280 and Erlotinib Hydrochloride in Treating Patients With Non-small Cell Lung Cancer,0.0009398035600048362,0.0008031383231178872
NCT01911325,Phase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) Patients,0.0008545641078640809,0.0007856234283386952
NCT01967095,Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung Cancer,0.0006233215722764196,0.0006103172140846516
NCT01909752,Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer,0.0007354174571614568,0.0008194469933510986
NCT01982955,Tepotinib With Gefitinib in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC),0.0006657728417866766,0.0008360326533105879
NCT01924416,Lung Cancer Information Study (LCIS-R01),0.000624089517663658,0.0004308197409913016
NCT01958931,Evaluate the Utility of the ProLung Test as Adjunctive to CT Scan in the Diagnosis of Lung Cancer,0.0004550718385273416,0.0007265520753062094
NCT01914120,the Quality of Life Assessment of Lung Cancer Patients in China,0.0009086593654929983,0.0007252649922017636
NCT01918761,Dacomitinib + Pemetrexed for Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC),0.0007944318362476406,0.0007596334276008559
NCT01963195,Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy,0.0006927454262090306,0.0009247062889547054
NCT01990261,A Study to Assess the Survival of Non-small Cell Lung Cancer Patients Treated With Tarceva After Failed Chemotherapy Treatment,0.000834650089898438,0.0009302361151674304
NCT01968941,Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer Patients,0.0006162003944902982,0.0005836951179509598
NCT01933828,Treatment of Early Stage Lung Cancer by VATS Versus OPEN Lobectomy,0.000536845563734348,0.0006017216274845467
NCT01928836,Risk Stratification of Patients Using the Lung Cancer Biomarker Panel in China,0.0007382137221850276,0.0007056227385466787
NCT01930474,Analysis of Plasma Tumor DNA in Lung Cancer Patients,0.0007421564157723018,0.0007166955050671631
NCT01987232,"Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Subjects With Previously Untreated Extensive Stage Small-cell Lung Cancer",0.0005344231611367906,0.00081435793361266
NCT01943578,Value of Physical Capacity Tests in Lung Cancer,0.0005303250432535828,0.00043893084113098385
NCT01998425,Circulating Fibrocytes in Non-small Cell Lung Cancer.,0.001319625915519793,0.0006025683013856788
NCT01998126,Combination Checkpoint Inhibitor Plus Erlotinib or Crizotinib for EGFR or ALK Mutated Stage IV Non-small Cell Lung Cancer,0.0006047238377228011,0.0006259764693158559
NCT01929200,Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation,0.0007340332558996581,0.0008802259048490472
NCT01993810,Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer,0.0007725920789520788,0.0008567754441139143
NCT01993550,Telephone Support Program for Lung Cancer Patients and Their Family Caregivers,0.0005888288309918518,0.00041413513958802207
NCT01991418,Early Warning Study of Serum Thioredoixn Reductase Activity in Excised Non-small Cell Lung Cancers (EWSOTRILC),0.0006668297958537936,0.000665349214151216
NCT01912625,"Trametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery",0.0007449475800388535,0.0009346622463673778
NCT01955343,Immune Response in Lung Cancer,0.000650758801426717,0.0006563740707017393
NCT01935336,Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers,0.00072851262974705,0.0007457541471038545
NCT01935947,Azacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0007848296400205771,0.0008256512888023334
NCT01951586,Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer,0.0006529349957784445,0.0006768331177428201
NCT01951469,Gefitinib With or Without Pemetrexed/Cisplatin in Brain Metastases From Non-small Cell Lung Cancer,0.0006158365916271582,0.0005974783104731236
NCT01951755,Phase IV Study of Tarceva in Patients With Advanced Stage IIIB/ IV Non-small Cell Lung Cancer (NSCLC),0.0008647575171435707,0.0009371007012759563
NCT01951482,Pemetrexed/Cisplatin With or Without Bevacizumab in Brain Metastases From Non Squamous Non-small Cell Lung Cancer,0.0006189434492994968,0.0005903735716199328
NCT01999673,Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung Cancer,0.0006710007214035585,0.0007457069980825358
NCT01999881,Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients,0.000647375594823829,0.0005652150816468158
NCT01999985,Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC),0.0006720258034122234,0.000770968457798178
NCT01999621,Determinants of Intensity of Care of Lung Cancer Patients With Organ Failure,0.0009090535150672984,0.0005217428186678271
NCT01949701,Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*02 Disease Controlled Advanced Non-small Cell Lung Cancer,0.0007241563740219959,0.0006873556623331096
NCT01949181,"Blood, Hair and Lung Concentrations of Metals and Metalloids in Patients With Lung Cancer or Chronic Obstructive Pulmonary Disease",0.0005684094138216256,0.0008153984824381907
NCT01949259,Rapid Learning for Lung Cancer,0.0009021799653660138,0.000592843927347286
NCT01941303,Analysis of Treatment Outcome and Toxicity in Non-small Cell Lung Cancer Patients Wither-irradiated to a High Dose for Recurrent Disease,0.0007544958052968998,0.0007715184677139113
NCT01931306,Expanded Access Study of Afatinib in Treatment-naive or Chemotherapy Pre-treated Patients With Non-small Cell Lung Cancer (NSCLC),0.0008336894289365116,0.0008882426312197704
NCT01964157,"An Open-label, Multicenter, Phase II Study of LDK378 in Patients With Non-small Cell Lung Cancer Harboring ROS1 Rearrangement",0.0008149135986842995,0.0008032683848288782
NCT01985113,Correlation Research of Thioredoxin Reductase in Lung Cancer,0.0009027698900798039,0.0005916063137414476
NCT01939210,Meditation-Based Breathing Training in Improving Target Motion Management and Reducing Distress in Patients With Abdominal or Lung Cancer Undergoing Radiation Therapy,0.0005782489090403543,0.0005774467102691747
NCT01938456,Safety and Tolerability of Trametinib in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung Cancer,0.0006175205178807708,0.0007349894011611271
NCT02630615,Circulating Tumor Cells (CTC) in Lung Cancer,0.0009068680738600622,0.0006466805550881275
NCT02619266,The Safety and Effect Study of Acupuncture for Anorexia in Patients With Gastrointestinal Tract and Lung Cancers,0.0006338962109453024,0.0007227350401515427
NCT02619448,Concurrent Chemotherapy and Accelerated Hypofractionated Radiation in Medically Inoperable Non-small Cell Lung Cancer,0.0006982963978249653,0.0007863319193984611
NCT02696863,Plan for Systematic Identification of Lung Cancers of Occupational Origin: Implementation Study,0.0006258880140263295,0.00046981084719478923
NCT02696525,Circulating Tumor DNA Detection in Surveillance of Surgical Lung Cancer Patients,0.0006196638693977485,0.0007759627666734165
NCT02686775,The PACO Project: A Clinical Study of a PAtient COach Program in Vulnerable Lung Cancer Patients,0.0006684167013044189,0.000691466797572182
NCT02665390,Percutaneous Cryoablation Peripheral Lung Cancer,0.0009027721503104027,0.0009924966388177696
NCT02612532,Lung Cancer Indicator Detection,0.0006479895339420853,0.0007322869337313145
NCT02644252,Tocotrienol as a Nutritional Supplement in Patients With Advanced Lung Cancer,0.0006458334976222503,0.0005837386045854942
NCT02688686,Safety and Efficacy of DC-CIK in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases,0.0008758029761065278,0.0008047958168980802
NCT02693080,CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy,0.0007485384704619186,0.0008015411061411083
NCT02608411,TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES),0.0006999980712577123,0.0009294979111351727
NCT02664792,Use of [18]F-FDG on PET/CT as an Alternative Non-invasive Method for Staging of Lung Cancer,0.0005337738901931594,0.0004203542801507821
NCT02638090,Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC),0.000776790294290801,0.0007158180994069253
NCT02655536,"Bevacizumab and Erlotinib in Lung Cancer With Brain Metastases, a Phase II Trial",0.0005590652285122873,0.0007096322663042052
NCT02671045,Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer,0.000664160417965878,0.000623588365625239
NCT02663492,Transcutaneous Electrical Acupoint Stimulation for Non-small Cell Lung Cancer Patients,0.000806054296616805,0.0007253562796907336
NCT02642042,Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell Lung Cancer,0.0007295930906204523,0.0008640634757453477
NCT02613637,Registry Study on Biological Disease Profile and Clinical Outcome in Patients With Newly Diagnosed or Existent Lung Cancer The LuCa Biology and Outcome (BiO)-Project,0.0006313875966032634,0.0007759675753129616
NCT02666755,Novel Detection System for Lung Cancer Curative Effect Monitoring,0.0006499765823267203,0.0007475229609177807
NCT02679963,Trial Evaluating Maintenance Olaparib in Patients With Platinum-sensitive Advanced Non-small Cell Lung Cancer,0.0007633311751986252,0.0008009446557387022
NCT02603627,"Prevalence of COPD in Our Lung Cancer Population, Compared to Controls",0.0017222839564628085,0.0009749388176209224
NCT02603367,COMFORT Caregiver Intervention in Improving Communication and Reducing Distress in Caregivers of Patients With Lung Cancer,0.0006375531416146459,0.0005160414391839376
NCT02629523,Afatinib in Lung Cancer With EGFR Mutation From Circulating Tumor DNA,0.000663756941795058,0.0009212479155362691
NCT02629458,A Study to Determine the Feasibility and Acceptability of Conducting a Phase III Randomised Controlled Trial Comparing Stereotactic Ablative Radiotherapy With Surgery in paTients With Peripheral Stage I nOn-small Cell Lung Cancer cOnsidered Higher Risk of Complications From Surgical Resection,0.0006852310361517979,0.0008356876467740492
NCT02691299,A Phase III Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer,0.0008000976535523832,0.0006852037238908027
NCT02695550,"Study of Safety, Efficacy and Pharmacokinetics of CT-707 in Patients With ALK-positive Non-small Cell Lung Cancer",0.0008216007512350834,0.0009290504715692476
NCT02675842,Investigation of Cannabis for Pain and Inflammation in Lung Cancer,0.0004755361090620184,0.0005833081030802909
NCT02607423,Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery,0.0007599654130468713,0.0008395767029437434
NCT02676050,Visualising c-MET and Activated Neutrophils in Lung Cancer,0.0009021799653660138,0.00047189857402550806
NCT02617186,Robotic Lobectomy vs. Thoracoscopic Lobectomy for Early Stage Lung Cancer,0.0005641994835318872,0.00043695726303968625
NCT02699229,Non-linear Multimodal Microendoscopy for Lung Cancer Pathology,0.0006400756134724817,0.0005099223136940902
NCT02699606,"A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or Cholangiocarcinoma",0.0006823441697955825,0.0007117504951984582
NCT02681549,Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer,0.0006098624715415098,0.0007841356658980953
NCT02673814,Phase 2 Trial of Durvalumab With or Without Bavituximab in Patients With Previously Treated Metastatic Non-small-cell Lung Cancer,0.000657986043938196,0.0007450291863374722
